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ABSTRACT
The formation of glycofluorophores and the fragmentation of proteins is only seen if  
glucose (or another reducing sugar) is included in the incubation. Although similar changes 
have been reported in the absence of sugars, it has been shown here that these changes are 
glucose dependent. Contrary to previous work, I  have shown that the presence of bound 
hpid on HSA does not alter the formation of Amadori product. Fragmentation of HSA is 
also unaffected by the presence ofbound lipid, but the formation of fluorescence by native 
HSA is 2.5 times greater than that of delipidated HSA. This shows that (i) tire enhanced 
fluorophore formation seen in native HSA is independent of the amount of Amadori 
product, (ii) that at least two con^onents of fluorescence on native HSA exist and (iii) that 
the mechanisms of fragmentation and lipid-dependent fluorescence formation are not the 
same.
Both fragmentation and fluorescence formation were inhibited by the transition-metal 
chelator DTPA, low ing that both these reactions are transition-metal catalysed. The 
formation of glycofluorophores appears to be partially dependent on the high afBnity 
binding of transition metals to the protein, but the glucose-induced fragmentation of both 
albumin and human transferrin occurs only when the transition metal species present is 
copper. No fragmentation of the iron binding protein transferrin is seen when iron is 
included in the incubations in the place of copper. Both these reactions were also inhibited 
by the use of HEPES buffer in the place of phosphate buffer. HEPES buffer, unlike 
phosphate buffer, has free radical scavenging properties so therefore it would appear that in 
addition to being transition-metal catalysed, these reactions are free radical mediated 
processes. The carbonyl scavenger, aminoguanidine, inhibited the production of 
glycofluorophores in^licating a carbonyl intermediate in this reaction. Pre-incubation of 
glucose with copper caused an increase in the amount of fluorescence initially observed 
indicating that autoxidation of glucose plays a role in fluorophore formation, although it is 
not possible to say whether this is a major reaction pathway or not.
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INTRODUCTION
1.1 Introduction
The spontaneous reaction between glucose and amino acids was first recorded by Maillard in 
1910. Until the 1970’s the Maillard reaction, which is characterised by the development of 
brown colour, fluorescence and crosslinking materials, was chiefly studied by food chemists 
[Bucala et al, 1991]. During the 1970's the chemistry of the Maillard reaction was found to 
occur in vivo and the measurement of early products of the reaction between reducing sugars 
and proteins became clinically important in the monitoring of diabetic long-term blood 
glucose control. There is now a large amount of evidence of the correlation between diabetic 
complications and high concentrations of blood sugar.
The first stage of the reaction is between a reducing sugar and an amino group on a protein; 
this produces an unstable aldimine, or Schiffs base. The Schiffs base forms rapidly, is very 
labile (its dissociation constant is nearly equal to its association constant) and reaches 
equilibrium with free glucose in a few hours [Baynes et al, 1984]. The Schiffs base can 
undergo the Amadori rearrangement to form a more stable ketoamine or Amadori product 
(see Figure 1.1). The formation of Amadori product is reversible, but in vitro it can take 3 
weeks or more for equilibrium to be reached, the rate of the back reaction being dependent 
on reaction conditions [Baynes et al, 1984]. It has been found that in haemoglobin, the rate 
constants for the formation and dissociation are 14.2xl0‘®s * and 1.7xl0 ®s'^  respectively 
[Mortensen and Christopherson, 1983]. In vivo the concentration of Amadori product is 
determined by the glucose concentration and the half life of the protein. Therefore, the 
Amadori product of haemoglobin (HbA^g) and human serum albumin (HSA) make them 
useful indicators of blood glucose control over a period of weeks [Schleicher and Wieland, 
1989]. Although the term glycation' is sometimes used loosely to cover any sugar induced 
protein modification, it is restricted in this thesis to its correct usage, i.e. to describe the 
formation of Amadori product.
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Figure 1.1: Formation of Amadori Product
1.2 Factors affecting givcation
In Vitro glycation is affected by temperature, incubation time (at least up to the point where 
the steady state is reached), pH (the nucleophilic addition of the amino group to the 
electrophilic carbon atom of the carbonyl group is governed by acid-base catalysis), and the 
concentration of the reactants. In vivo the major variable is the concentration of reactants, 
hence the extent of in vivo glycation is determined by the concentration of blood glucose and 
the half-life of each protein [Schleicher and Wieland, 1986].
Glycation rates are also affected by the type of reducing sugar which is reacting with the 
protein. Bunn and Higgins (1981) investigated the covalent binding of radioactive sugars to 
haemoglobin using a variety of sugars. They found that with all the sugars the covalent 
binding to haemoglobin was linear with time. They also found a strong correlation between 
the rates of reactivity of the sugars with haemoglobin, and the percentage of each sugar 
found in the open chain form. It is necessary for the sugar to be in the acyclic form in order 
for the carbonyl group to exist. Two factors other than the percentage of sugar present in the 
acyclic form were found to affect the rate of the reaction between reducing sugar and 
haemoglobin; (i) ketoses are less reactive than aldoses (probably because an aldehyde 
carbonyl carbon atom is a stronger electrophile than a ketone carbonyl carbon), and (ii) the 
presence of charged groups on the sugar can influence its reactivity with haemoglobin.
Glucose is a relatively unreactive sugar and only 0.002% exists as the acyclic form. In 
contrast, fructose has 7.5 times greater reactivity with haemoglobin (despite being a ketose) 
and has 0.7% existing as the open chain form [Bunn and Higgins, 1981].
The formation of Amadori products from Schiffs base can be accelerated by acid-base 
catalysis. In HSA, the amino acid sequence around glycation sites was examined, and it was 
found that the lysine residues glycated in vivo often appear in a sequence with proton- 
donating amino acid residues. In HSA, Lys-525 is the principal site of in vivo glycation with
some glycation of lysine residues 439 and 534. Lys-525 is part of a Lys-Lys sequence, Lys- 
439 is part of a Lys-His sequence and Lys-530 is in a Lys-His-Lys sequence. Other lysine 
residues in HSA which are glycated in vitro, such as Lys-199, appear in the primary 
structure close to disulphide bridges, which may hold proton- donating residues from other 
sections of the chain close enough to lysine residues to act as catalysts of the Amadori 
rearrangement [Iberg and Fliickiger, 1986].
1.3 Consequences of Amadori product formation
The formation of Amadori product can inactivate certain enzymes [T^guchi et al, 1989] 
and can lead to conformational changes in lens a  and y crystallins [Beswick and Harding, 
1987] and HSA [Shaklai et al, 1984]. The glycation-induced conformational change in 
HSA does not appear to affect its function in vivo [Murtiashaw and Winterhalter, 1986]. 
The glycation of lens crystallins results in loss of positive charges and leads to a change in 
conformation which allows previously unexposed thiol groups to participate in disulphide 
bonds [Beswick and Harding, 1987]. The Amadori product itself is reactive and can 
undergo many post-Amadori reactions which lead to compounds with the general name of 
Maillard products. There is increasing evidence that protein glycation alone (the formation 
of Amadori product) is not sufficient to cause the complications seen in diabetes. It has 
been found that there is no age linlœd increase in the amqunt of Amadori product found in 
collagen of human skin or basement membranes, or in lens proteins of patients older than 5 
years old [Baynes and Monnier, 1989]. A recent study by Scalbert and Birlouez-Aragon 
(1993) showed that the fluorescence of human lens proteins increased W h age and 
cataracts, but the amount of Amadori product remained constant. This would appear to 
lend weight to the idea that it is not the accumulation of Amadori products that is the cause 
o f diabetic complications, but the products of ppst-Amadori reactions. Therefore this thesis 
has concentrated on the formation of these products.
1.4 Post-Amadori Reactions
The products of post-Amadori reactions are known as advanced glycation endproducts, or 
AGEs, and include crosslinks, fluorophores, melanoids and peptide fragments resulting from 
nonenzymatic proteolysis. To date very few of these reactions or their products have been 
satisfactorily characterised. One of the commonest ways of monitoring AGE formation is 
to look at the build-up of fluorescence. This is one approach adopted in this thesis, using 
the wavelength characteristic of pentosidine (see Section 1.4.2). The other approach used 
here is to monitor protein fragmentation (see Section 1.8).
1.4.1 3-Deoxvglucosone
Food chemists first detected 3-deoxyglucosone as a degradation product of Amadori 
products refluxed under acidic conditions in the 1960s (see Figure 1.2) [Anet, 1964]. Kato 
et al (1987) found that 3-deoxygIucosone is produced under physiological conditions in in 
vitro Maillard reactions, and that 3-deoxyglucosone is the species responsible for the 
glucose-induced crosslinking of lysozyme in vitro. It was found that 3-deoxyglucosone was 
the major carbonyl compound in the low molecular weight fraction of incubation media in 
which either fructose or glucose was incubated with protein to form Amadori product [Shin 
et al, 1988]. The amount of 3-deoxyglucosone produced during in vitro protein glycation is 
dependent on the number of free lysine residues. The generation of 3-deoxyglucosone is 
suppressed if the lysine residues are blocked by acétylation. The production of 3- 
deoxyglucosone from fhictose is unaffected by the availability of lysine residues implying 
that 3-deoxyglucosone can be formed from fructose independently of an Amadori 
intermediate [Shin et al, 1988].
In  vitro 3-deoxyglucosone has been shown to be involved in the production of both 
crosslinks and the uncharacterised fluorescent product L I and its role in the formation of
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the well characterised AGE, pyrraline, has been postulated [Kato et al, 1989; Knecht et al, 
1992]. The formation of AGEs from 3-deoxyglucosone can be inhibited by 
aminoguanidine. Studies by Igaki et al (1990) in which both 3-deoxyglucosone and 
Amadori products were treated with aminoguanidine showed a reduction in crosslink 
formation. This suggests that 3-deoxyglucosone is responsible for the crosslinks, and that 
the Maillard reaction proceeds through dicarbonyl intermediates such as 3-deoxyglucosone.
In  vivo it is thought that 3-deoxyglucosone is formed from glucose either via its Amadori 
product (which rearranges to regenerate the free amino group and produce 3- 
deoxyglucosone), or via the polyol pathway in which glucose is converted to fructose which 
undergoes a rearrangement and a dehydration to give 3-deoxyglucosone [Knecht et al, 
1992]. This may be of particular concern in diabetes owing to the increased activity of the 
polyol pathway [Baynes and Monnier, 1989]. It is thought that 3-deoxyglucosone is 
converted enzymatically to the less reactive species 3-deoxyfructose. Both of these 
compounds have been detected in human urine. This would suggest that the ability of an 
individual to convert reactive 3-deoxyglucosone to the less reactive 3-deoxyfructose could 
be a factor determining the extent of development of diabetic complications [Knecht et al, 
1992]. Recent work by Niwa et al (1993) has shown that the serum levels of 3- 
deoxyglucosone are elevated in diabetics and especially so in those with nephropathy.
1.4.2 Pentosidine
Pentosidine is a fluorescent crosslink with excitation and emission maxima of328nm and 
378nm respectively (Figure 1.2). It is formed between lysine and arginine residues by a 
five-carbon sugar. It was characterised by Sell and Monnier (1989) after extraction from 
human dura mater collagen from diabetics and then synthsised in vitro by reacting lysine and 
ar^nine with D-ribose. At first, pentosidine could not be detected in the products from the 
reaction between lysine, arginine and glucose or any other hexose, so it was concluded that 
pentosidine must be formed by reaction of lysine and arginine with pentoses. However,
Grandhee and Monnier (1991) were able to detect the slow formation of pentosidine from 
BSA incubated with glucose, fructose or ascorbate. From further studies it was established 
that the Amadori products of glucose and fructose with lysine were in fact precursors of 
pentosidine and the pentose reaction product furfural was not a precursor o f pentosidine, 
although pentoses could contribute to the formation of pentosidine through another route.
After in vitro glycation with glucose, pentosidine only makes up 0.001 moles of each mole 
of lysozyme dimer formed [Dyer et al, 1991a]. It is found to increase with both age |md 
diabetes in vivo and is the only fluorescent AGE to be characterised so far. Its use as a 
biomarker for the Maillard reaction in vivo was postulated by Dyer et al (1991b). Sell and 
Monnier (1990) showed, in a study linking diabetic complications with pentosidine levels, 
that all the diabetics with elevated pentosidine levels had retinopathy. It has also been 
demonstrated that diabetics have elevated urinary levels of pentosidine, with an excretion of 
75pg per day compared to 29|xg per day in control patients [Takahashi et al, 1993]. In this 
study, glucose-induced fluorescence was monitored using the excitation and emission 
maxima of isolated pentosidine.
1.4.3 Furovl-furanvl imidazole fFFD
In 1984 Pongor et al identified an AGE that was believed to be formed from condensation 
of two Amadori products, but this was later shown to be an artefact of the extraction 
process [Njoroge et al, 1988].
1.4.4 Pvrraline
Pyrraline and other pyrroles are believed to be formed from the reaction between free amino 
groups on lysine residues and 3-deoxyglucosone. An ELISA was developed for pyrraline, 
as it is destroyed by acid hydrolysis so cannot be detected by most chemical methods.
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Using this assay, Hayase et al (1989) showed that diabetics had elevated levels of pyrraline 
bound to HSA compared to normal patients.
Another group of related compounds that have been formed in vitro from reactions of 
Amadori product with 3-deoxyglucosone are the AFPGs (l-alkyl-2-formyl-3,4-diglycosyl 
pyrroles). These were isolated by using sulphites to inhibit the later reactions in the 
Maillard reaction to trap intermediates such as these compounds [Bucala et al, 1991]. The 
use of sulphites as inhibitors of the Maillard reaction is widespread in the food industry. 
The structures of pyrraline and AFPG are shown in Figure 1.2.
1.4.5 CML
The Amadori product can undergo oxidative cleavages to form carboxymethyl lysine 
(CML) and erythronic acid (EA), or lysino-lactic acid (LL) and glyceric acid, depending on 
whether the cleavage occurs between C2 and C3 or C3 and C4. CML and EA are the 
major products in this reaction. CML and LL are both colourless and much less reactive 
than the Amadori product. Both CML and LL are found in urine and in hydrolysates of lens 
proteins [Ahmed et al, 1988; Ahmed et al, 1986].
NH-
W 4
CM
H2N COOH
Pentosidine
COOH
HOH2C
R
■OHO
Pyrraline AFGP
OHO
^ = 0
%  
HCOH
HCOH 
CHgOH
3 -Deoxyglucosone
Figure 1.2: Structures of 3-deoxyglucosone and the AGEs pentosidine, pyrraline and 
AFGP (l-alkyl-2-formyl-3,4-diglycosyl pyrroles)
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1.5 The role of oxidation in AGE formation
Over the past few years, it has become clear that the severity of diabetic complications is 
related not to the build up of Amadori product, but to post-Amadori reactions producing 
AGEs. There has been increasing interest in the role of oxidation in the reactions between 
reducing sugars and proteins. The term glycoxidation is now used to define reactions that 
involve both reaction with a sugar and an oxidative step.
Apart from two reactions, the reversal of the Amadori reaction with the regeneration of 
Schiffs base and possibly the formation of 3-deoxyglucosone, all reactions of the Amadori 
product documented so far require aerobic conditions. These reactions include the 
formation of CML [Ahmed et al, 1988], pentosidine [Grandhee and Monnier, 1991], sugar- 
induced fluorescence and crosslinking [Fu et al, 1992] and other products of the "browning 
reaction' [Fu et al, 1992]. Pyrraline and AFPGs are believed to be formed through 
interactions between 3-deoxyglucosone and free amino groups on proteins, although it is 
not clear yet if an oxidation step is involved in this reaction [Hayase et al, 1989].
All these 'glycoxidative' processes must be transition metal catalysed, as dioxygen exists in 
the triplet ground state and biomolecules such as proteins exist in singlet ground state. This 
makes reaction between them a spin forbidden process. Although the reaction is 
thermodynamically favourable, differences in the spin multiplicity of reactants cause the 
activation energy of the reaction to be prohibitively high. Some transition metals can exist 
in several spin states and are usually co-ordinated to biomolecules by their'd' orbitals. The 
association of Og to transition metals can also occur through the'd' orbitals of the metal.
This allows the transition metal to act as a bridge across the spin forbidden gap, and hence 
the activation energy of the reaction between O2  and biomolecules is lowered sufBciently
for it to proceed [Miller et al, 1990].
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Experiments quoted throughout the literature show that these glycoxidative reactions are 
metal-catalysed oxidation reactions. Adding DTPA (a metal chelator) to in vitro glycation 
incubations prevents the formation of fluorescence ^ d  crosslinks in collagen and albumin 
[Fu et al, 1992; W olff and Dean, 1987]. The inhibition of these reactions by metal chelators 
reinforces the idea put forward by Miller et al (1990) that traces of transition metals found 
in buffers such as phosphate and Tris are responsible for catalysing oxidation reactions.
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1.6 The role of glucose autoxidatioa products
An alternative ^proach to the established glycation theory was put forward by Wolff and his 
grorg) in 1987. This is not widely accepted [Harding and Beswick, 1988] and there is now a 
large amount of evidmce that shows that this pathway can only be a very minor one (see Section 
1.7). Wolff pointed out that ^ ucose is an a-hydroxy aldehyde vhich is in equilibrium with its 
enediol. The enediol can undergo euediol oxidation in the presmce of oxygm and a transition 
metal catalyst, forming an a-ketoaldehyde. This reaction occurs via the enediol radical anion and 
generates hydrogen peroxide. The a-ketoalddryde is postulated by Wolff to react with a ffee 
amino grorp on protein to give a ketoaminemethylol which rearranges to a ketoimine (Figure 
1.3). The ketoimine would be the first stable protein-sugar adduct and it would be sim ilar to the 
Amadori product (a ketoamine). Unfortunately Wolffs theory has bear difficult to test because 
the product of the ketoimine in the sodium borohydride glycation assay that he used is 
indistinguishable j&om the product formed by the ketoamine (or Amadori product).
Wolff and Dean (1987) showed by incubating BSA and glucose in the presence and absence of 
the transition metal chelator DTPA, that 45% of protein-sugar adducts were formed by the 
gluœse autoxidation pathway. More recent work from Baynes' laboratory shows that the 
formation of Amadori compounds is independent of whether the reaction takes place under 
aerobic or anaerobic conditions, althou^ post-Amadori conpounds are only produced under 
oxidative ccmditicms [Fu et al, 1992]. This inphes that it is the Amadori product rather than the 
ketoimine that is the major product whm glucose and proteins are incubated under either 
oxidative or non-oxidative conditions. Therefore it is unlikely that the autoxidation of glucose is 
a major reaction pathway throu^ which AGEs are formed.
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1.7 Radical reactions and the Amadori product
There is increasing evidence that AGE formation involves post-Amadori reactions in which 
free radicals are generated by the autoxidation of Amadori product. Cillery et al (1988) 
detected the formation of superoxide from model Amadori compounds and from glycated 
proteins, but not from glucose, suggesting again that the autoxidation of glucose under 
physiological conditions is not a major reaction pathway. Superoxide radical production 
from model Amadori products, i.e. from incubations of reducing sugars and amino acids, 
was also shown by Azevedo et al (1988) by following the reduction of NBT. Kawakishi et 
al (1991) also found that the Amadori product mediated protein fragmentation similar to 
that caused by oxygen radicals, and suggested that the Amadori product could undergo 
autoxidation reactions similar to the one outlined in Figure 1.3. It seems that the most 
likely route for autoxidative damage would be via the Amadori product, as work carried out • <
in the three groups mentioned above shows that the Amadori products produced oxygen 
radical species, whilst none were detectable in incubations of reducing sugars alone.
Glycated proteins have been found to act as both radical scavengers and producers of 
superoxide radicals. Glycated BSA scavenges both hydroxyl radicals and hydrogen 
peroxides to a greater extent than non-glycated BSA, although the glycated BSA has a 
lower scavenging ability for superoxides than the non-glycated BSA [Okamoto et al, 1992]. 
Hence with some glycated proteins the role of free radicals may be difficult to assess, 
particularly as it has been postulated by Halliwell (1988) that radicals once produced, 
immediately attack the protein and are not released into solution.
The production of free radicals by the oxidation of glycated proteins in the presence of 
catalytic transition metals has been shown to enhance lipid peroxidation in membranes and 
linoleic/arachidonic acid vesicles [Mullarkey et al, 1990]. Lipid peroxidation has been 
initiated by a glycated polylysine molecule that is associated with an iron^^  ion [Sakurai et 
al, 1990].
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1 8 Protein fra^entaricm
The non-enzymatic fragmentation of three different proteins (BSA, ciystallin and LDL) has hem 
shown to occur by incubation of protein with reducing sugars [Hunt et al, 1988a; Hunt and 
Wolff, 1990; Hunt et al, 1990]. In the absmce of sugar fragmentation can be induced by 
radiolysis of the protein [Wolff and Dean, 1986; Davies, 1987] and by incubation of the protein 
with radical generating systems such as ascorbate/Cu? [Marx and Chevion, 1985]. It was also 
found that BSA could be fragmented by incubating it with model Amadori products in the 
presQice of Cu“ [Kawakishi et al, 1990]. hi every fragmentation system except direct radiolysis, 
the presence of Cu“ ions was required for the reaction to proceed, and it was inhibited by the 
inclusion of metal chelators such as DTPA and EDTA [Fong et al, 1987; Hunt et al, 1988a; 
Kawakishi et al, 1990].
Many experiments have been carried out to demonstrate the free radical nature of the 
fragmentation reaction, and to attenpt to identify the reactive species. Extensive studies by 
Davies and Deloignore (1987) using °^Co irradiation have shown that the hydroxyl radical 
initiates reactions that alter the structure of BSA, but in order for fragmentation to be observed 
both molecular oxygen and the siperoxide radical must be present. Inhibition of fragmmtation 
was observed on addition of the hydroxyl radical scavengers benzoic add, deoxyribose and 
sorbinil to the glucose fragmentation system of Hunt et al (1988a) and on addition of mannitol to 
the ®®Co fragmentation system of Davies and Deloignore (1987). This shows that the hydroxyl 
radical is an active spedes in the fragmentation of proteins whether the reaction is initiated by 
irradiation or a ghicose/Cu  ^system.
Fragmentation of BSA incubated with Amadori product or glucose is inhibited whm catalase is 
included in the incubations, showing that hydrogen peroxide is necessary for protein 
fragmentation under these conditions [Kawakishi et al, 1990; Hunt et al, 1988a]. Direct 
incubation of BSA with HgOg and dther Cu° or Fe™ has also produced protein fragmentation 
[Wolff and Dean, 1986]. It is likely that the hydrogen peroxide undergoes the metal- catalysed
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Fenton reaction and produces hydroxyl radicals if the mechanisms of protein fragmentation 
deduced from the radiolysis work [Davies and Deloignore, 1987] (vdiere hydroxyl radicals have 
bem found to be the initial reactive species) gpply in this reaction.
Hunt et al (1988a) piit forward the idea that protein fragmentation was not dqxendent on the 
production of Amadori product, but was a result of the glucose autoxidation reaction. 
However,the fragmeitation of BSA incubated with Amadori product in the presence of Cu° 
shows that Amadori products do play a major role in the fragmentation of proteins [Kawakishi et 
al, 1990], and this is further evidence against glucose autoxidation being a major pathway for 
"glycoxidative damage".
These rqxorts suggest that sugar-induced protein fragmentation is one of the major post-Amadori 
reactions and may therefore be responsible for diabetic conphcations. The mechanism of sugar- 
induced fragmaitation was therefore investigated in this study.
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1.9 Lipid Peroxidation
The peroxidation of Ipids is of interest in this study because serum albumin is a Ipid transporting 
protein. In vivo, HSA has 1=2 moles of fatty acid bound per mole of protein. It has been 
rqxorted that the peroxidation of lipids produces fluorescence with maxima similar to those of the 
products of glycoxidative reactions [Jones and Lunec, 1987]. In purified firaction V  HSA, 
^roximately 65% of bound fatty acids are unsaturated with about 6 % of the total being 
polyunsaturated (containing three or more olehnic bonds) [Saifer and Goldman, 1961]. It is 
inportant to note that saturated fatty acids do not undergo lipid peroxidation reactions and mono- 
and di-unsaturated fatty adds do so only at very slow rates [Halliwell and Gutteridge, 1989].
Lipid peroxidation is initiated by the abstraction of a proton firom a methylene group. This is 
fadhtated if the adjacait carbon atom is a olefinic carbon, as the methylene C-H bond is 
weakened by the close proximity of the double bond. The abstraction of the proton leaves a 
carbon-centred radical. This undergoes a molecular rearrangement in which the carbon centred 
radical is stabilised by the production of conjugated double bonds (conjugated dienes absorb at 
234nm and Ûiis is often used as a measure of the extent of lipid peroxidation). The carbon 
centred radical can combine with oxygen to form a peroxyl radical, form crosslinks with another 
radical, or attack a protein molecule. This reaction can be propagated by peroxyl radicals as they 
are capable of abstracting protons from methylene groiqxs [Halliwell and Gutteridge, 1989].
The abstraction of the methylene proton that initiates lipid peroxidation can be by a hydroxyl or 
peroxyl radical. The siqxeroxide radical is insufficiently reactive to abstract a proton from lipids, 
althou^ if Fe° is present then hydroxyl radicals can be produced through the scheme shown 
below.
(1)'0-2 + H+ -------------------------- > Ho;
(2) HO; +'02- + H+ -------  -> H2 O2  + O2
Fenton reaction (3) Fë^  ^+ HgOg ------------------  > Fe^"^+*0H + “OH
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Superoxide has been shown to form from Amadori products [Cillery et al, 1988; Kawakishi 
et al, 1991; Azevedo et al, 1988]. Therefore, if  the superoxide radical is capable o f forming 
a hydroxyl radical in the presence ofFe^+ under conditions that favour the Fenton reaction, 
then it might be expected that glycated proteins would be able to act as initiators of lipid 
peroxidation.
A study by Hicks et al (1988) showed that both glycated collagen and glucose are capable 
of catalysing lipid peroxidation in linoleic/arachidonic acid vesicles. The lag phase before 
hydroperoxide production was dependent on either the amount of glucose present, or the 
extent of glycation of the collagen, whereas the final rate of lipid peroxidation was 
independent of this.
Malondialdehyde is one of the many secondary products of the lipid peroxidation reaction 
and is formed from cleavage of the carbon backbone of alkoxyl radicals. It is an extremely 
reactive dicarbonyl compound, which when incubated with proteins in vitro forms 
fluorophores and crosslinks. The fluorophores are similar to those found in aged tissues 
with excitation maxima at 350-400nm and emission maxima at 450-470nm. Fluorophores 
derived from the reactions of linoleic, linolenic and arachidonic acids with proteins have 
excitation and emission maxima in the range of those of glucose-derived fluorophores 
[Kikugawa and Beppu, 1987].
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1.10 Methods for measuring elvcation
Although this thesis is mainly concerned with post Amadori reactions, glycation has been 
measured in some cases in order to determine which part of the reaction sequence is 
affected by factors such as lipid or alternative reducing sugars. There is a wide variety of 
techniques used throughout the literature and differences in the techniques should be taken 
into account when comparing results.
Two main classes of techniques are used to determine the extent o f glycation of proteins. 
The first depends oh the separation of glycated and non-glycated proteins and the 
subsequent determination of the amount of protein in each fraction. Techniques relying on 
the separation of glycated from non-glycated proteins include isoelectric focusing, gel 
electrophoresis, ion-exchange chromatography and affinity chromatography using phenyl 
boronate affinity gel. O f these methods, phenyl boronate affinity chromatography is the 
most commonly used, but results from this are not consistent between labs as it varies 
widely with chromatographic conditions. However, the use of an automated form of this 
assay is used throughout clinical labs. With all separation techniques each protein molecule 
can only be counted once, so even if a protein molecule has more than one mole of Amadorif 
product bound to it the results from these techniques will read it as one, and hence give an 
underestimation of the true value of the extent of glycation [Furth, 1988].
Chemical assays ensure that every mole of Amadori product is measured, so even on multi­
glycated proteins they probably give a more accurate value for the total glycation of 
proteins. There are four principal chemical assays used to measure glycation.
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1.10.1 Serum fructosamine assay
This assay utilises the reducing power of the enediol, that forms on alkali treatment of the 
Amadori product. The amount of enediol produced is quantified by the amount o f blue 
colour formed as nitroblue tétrazolium is reduced. There is no fixed endpoint to this assay 
and standardising it can be difficult, but for clinical uses this assay has become automated to 
help reduce problems associated with the standardisation.
1.10.2 Borohvdride reduction
Borohydride reduces the specific double bonds (C=N in the Schiffs base and C=0 in the 
Amadori product) to a stable sugar-amino acid link which is able to withstand boiling in 6 M  
HCl. Boiling in HCl hydrolyses the peptide bonds and the sugar-amino acid adducts are 
then quantified by amino acid analysis. This can be one of the most sensitive of the 
glycation assays if radio labelled reagents are used.
1.10.3 TBA assay
This assay is one of the oldest chemical assays used for glycation. The glycated proteins are 
boiled in oxalic acid, releasing 5-hydroxymethyl furfural (HMF). The HMF is 
colorimetrically quantified by reacting it with TB A after the protein has been removed fi*om 
solution by acid precipitation. This assay is not specific to Amadori product and any hexose 
will give HMF on boiling with oxalic acid, although the Schiffs base does not interfere with 
this assay.
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1.10.4 Periodate oxidation
The periodate reagent cleaves molecules between adjacent hydroxy groups or, as occurs in 
Amadori products, between hydroxy and carbonyl groups. The major product from this 
reaction is performic acid, but one of the minor products, formaldehyde, is released only 
from C-1 and C- 6  in straight chain hexoses that are adjacent to a carbon atom with either a 
hydroxy or a carbonyl group. This property makes the measurement of formaldehyde 
production (either by fluorescence after conversion to diacetyldihydrolutidine (DDL) or by 
absorbance of DDL at 412nm) [Ahmed and Furth, 1991] a particularly specific assay of 
Amadori product. It is a version of this assay adapted for a microplate reader that is used in 
this thesis.
1.10.5 Furosine assav
Although not strictly a chemical method, the furosine assay is probably the most sensitive 
and specific of the glycation assays, detecting only glycation of lysine residues. Glycation of 
the N-terminal residues must be assayed by amino acid analysis or one of the other methods 
mentioned above. Glycated proteins that have not been pre-treated in any way are 
hydrolysed by boiling in 6 M  HCl, producing furosine. The furosine is separated from the 
other products of acid hydrolysis by HPLC and detected by absorbance at 280nm. There is 
only a 30% yield of furosine from lysine-bound Amadori product, but the assay is not 
affected by Schiffs base, enzymatically bound sugar residues or free sugar.
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1.11 Human Serum Albumin
The protein used in much of the work in this project was human serum albumin (HSA). 
HSA is a nonglycoprotein which makes up approximately 60% of plasma proteins. It is a 
single chain polypeptide of 585 residues and has a molecular mass of 66.4kD. It contains 
only one tryptophan residue [Peters, 1985]. It has a high number of charged residues; 36 
aspartic acid, 62 glutamic acid, 59 lysine and 24 arginine and has a net charge o f-15 at 
pH7. It is this high concentration of charged residues that helps to make HSA a soluble 
protein. There are 35 cysteine residues in HSA forming 17 disulphide bridges which hold 
the molecule in 9 loops and contribute to its high stability [Peters, 1985]. The 9 loops form 
three domains which have a large amount of amino acid homology, and are each fiirther 
divided into two subdomains, A  and B (Figure 1.4). Subdomains lA , IB and ÜA are closely 
packed together forming the conqxact head of the molecule, whilst subdomains IIB , UIA  
and rnn are more loosely associated and form the elongated tail of the molecule [Carter et 
al, 1989]. The overall shape of the HSA molecule is an ellipsoid and its dimensions are 40 
x 14GÂ with an axial ratio of 3.5. Not all the molecular space is taken up by the 
polypeptide chain, and approximately 2 0  water molecules are associated with specific sites 
on HSA. In addition there is the hydration shell of water molecules that are hydrogen- 
bonded both to the protein and to one another [Peters, 1985].
HSA fimctions as a transport protein and is able to bind a large range of Hgands including 
inorganic cations, organic anions, various drugs, amino acids, bilirubin hemin and fatty 
acids. Most associations with HSA involve hydrophobic interactions, althou^ a few 
classes of compound bind to HSA either by ionic interactions or covalently. Possibly the 
most important hydrophobic interactions in vivo are between HSA and long chain fatty 
acids.
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Figure 1,4: Model of serum albumin molecule [Peters, 1985]
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1.11.1 Binding of long chain fattv acids to HSA
The binding of long chain fatty acids to HSA is of particular interest to this project because 
o f the possibility of them undergoing peroxidation reactions, and because of the 
conformational change they cause in HSA when they bind.
The maximum number of fatty acids that can be loaded onto HSA is 6 , both in vivo and in 
vitro, although in vivo a loading of 6  is normally only found after renal dialysis and even 
after severe exercise the maximum loading is 4. In  vivo HSA usually carries 1-2 moles of 
fatty acid per mole of protein and these can be removed from the protein without denaturing 
it by using charcoal treatment [Peters, 1985; Chen, 1967].
The binding constant for the binding of fatty acids to HSA is about two orders of magnitude 
higher than for most other ligands that bind to HSA, with the main energy of binding being 
due to hydrophobic interactions [Brown and Shockley, 1982]. The long chain fatty acids 
bind in their salt form to HSA. The central part of the fatty acid chain is held rigidly, whilst 
the ends are free to move. The binding affinity of fatty acids increases with chain length for 
the first 2-3 high-afBnity binding sites, indicating that hydrophobic interaction rather than 
ionic interaction is the major binding force [Peters, 1985].
The fatty acids bind to HSA with graded affinity, the fourth fatty acid to bind having less 
than one tenth of the binding affinity of the first [Peters, 1985]. The strongest binding site 
has been shown to be subdomain IIIA . The remaining 3 specific sites of fatty acid binding, 
in order of affinity, are the interface between domains n  and m , the centre of domain I and 
the centre of domain II [Carter et al, 1989; Peters, 1985]. The binding of fatty acids at the 
first two binding sites (subdomain IIIA and between domains II and m ) causes a 
conformational change in the molecule in which the C-terminal end (subdomains IIIA, BIB 
and nB) is compacted. This results in a change in the dimensions of the molecule to 40 x 
130 A with the axial ratio changing from 3.5 to 2.2 [Droge et al, 1988; Peters 1985].
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1.11.2 Binding of tryptophan, tvrosine and organic anions such as drugs
The amino acids tryptophan and tyrosine both bind to HSA at the same site and are the only 
amino acids to bind to HSA non-covalently. Competition data shows that the same site also 
binds short chain fatty acids and organic anions such as diazephines, naproxen, clofibrate 
and flufenamic acid. The binding site has been termed as 'site II' and is located in domain 
m . The binding affinities for the organic anions are in the range of log K^= 4 to 6  whereas 
for long fatty acids log K/^ is about 8 . The binding of ligands at this site is affected if  more 
than 2-3 moles of long chain fatty acids are bound to HSA. It is not known whether this is 
because of the conformational change induced by the binding of the long chain fatty acids or 
because the long chain fatty acids bind at this site themselves [Peters, 1985].
1.11.3 Ligands that bind covalentlv to HSA
The covalent binding of glucose and other reducing sugars to HSA has been reported 
widely and is o f particular interest in this study (see Section 1.12). Several other classes of 
compound bind covalently to HSA. They include pyridoxal phosphate, aspirin and amino 
acids which form mixed disulphide bonds with residue Cys-34. The covalent attachment of 
aspirin is a result of a condensation reaction between its acetyl group and the 8 -amino group 
on residue Lys-199, which is one of the major sites of in vitro glycation.
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1.11.4 Binding of inorganic cations
i) Calcium
Half the plasma calcium is bound to HSA and an average of two moles of Ca^ "^  per 
mole of HSA is normally found in vivo. The binding of calcium to HSA is not 
specific and the binding constant is low [Peters, 1985].
ii) Copper
As AGEs are thought to form via metal-catalysed oxidation reactions, the binding of 
copper to HSA may be important in the formation of its glycoxidative products. 
Albumin binds approximately 7% of serum copper. The remaining copper is tightly 
bound to ceruloplasmin and is not exchangeable in vivo. The copper bound to 
albumin is rapidly exchanged with the copper in the tissues and therefore albumin is 
considered to be a major transport protein of copper [Sarlcar, 1983], The copper 
bound to ceruloplasmin is not oxidatively active but copper bound either to albumin 
or His residues is still able to catalyse the Fenton reaction (see Section 1.9), 
although the reactive OH radical species formed is thought to attack the molecule to 
which the copper is bound, and the radical is not released into solution [Halliwell 
and Gutteridge, 1989].
Under normal conditions there is less than one mole of copper per mole o f albumin, 
but in conditions such as Wilson's Disease (a hereditary deficiency of ceruloplasmin) 
copper levels in serum are elevated. Although early work on albumins showed that 
they had many copper binding sites, the presence in vivo of less than one equivalent 
of copper makes the first copper binding site of much greater physiological 
importance than the other sites. Early work carried out by Naik et al (1975) on 
BSA, showed two distinct classes of binding site. The first three sites had a high 
affinity for copper ions, whilst the remaining 16 showed a much weaker affinity.
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The average binding constant for the three high affinity sites is log K^= 6 .5 , and the 
binding constant for the remaining sites is log K/^ =4.3. These studies were carried 
out using a cupric-ion-specific electrode [Naik et al, 1975]. Later work has shown 
that most albumins have a single high affinity copper binding site, with further lower 
affinity binding sites.
Not all serum albumins bind CuP with the same affinity at a single high affinity 
binding site. It has been shown that BSA, HSA, and rat serum albumin (RSA) had a 
preferential binding site of h i^  affinity for one Cu^ ion. This binding site is not 
present in chicken serum albumin (CSA) or dog serum albumin (DSA) which led to 
further study of the N-terminal binding site [Appleton and Sarkar, 1971]. Before the 
N-terminal sequences of these albumins had been completed it was established that 
the His residue which forms part of this binding site is absent in DSA.
In a recent paper by Predkl et al (1992), this high affinity binding site was 
characterised and compared to the N-terminal sequences of RSA, HSA, BSA, 
porcine serum albumin (PSA), DSA, and CSA. The N-terminal co-ordination site is 
square planar using the N  atom of the His residue in position 3 of the amino acid 
sequence. In DSA and PSA there has been a substitution to a Tyr residue and in 
CSA an insertion of Glu at position 3 puts the His residue into position 4. DSA 
binds the first equivalent of copper at two sites of equal specificity, although these 
sites are of much lower affinity than the high affinity site o f HSA [Appleton and 
Sarkar, 1971]. Predkl et al found that co-ordination of metals to DSA and CSA are 
similar, showing that the His residue has to be at position 3 if  the binding site is to 
have a high affinity.
The postulated high affinity site on BSA and HSA is square planar with the four co­
ordinating atoms being the N-terminal N  atom, 2 backbone N  atoms and the 
imidazole N  atom from the His residue in position 3. The aspartyl carboxylate 
group from position 1  in HSA also co-ordinates to the bound Cu^ ion. In CSA and
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DSA, the square planar co-ordination site has the N-terminal N  atom and three 
backbone N  atoms as the "comers" (Laussac and Sarkar, 1984]. Synthetic 
polypeptides to mimic the square planar binding site of albumins have been made by 
the laboratories of Sarkar [Laussac and Sarkar, 1984]. Both the peptides prepared 
had a His residue in position 3 and have been found to bind Cu^ ions with similar 
affinity to the principal copper binding albumins.
iii) Nickel
Nickel binds to HSA at the same site as copper, but with a much lower affinity. The 
binding constant for nickel is log K^=9.6 and the binding constant for copper 
binding at this site is log K/^ =16. As a result of this difference in binding affinities, 
nickel is displaced from the specific binding site on HSA by copper [Peters, 1985].
iv) Other metals
The binding of metals other than copper and nickel seems to be much more ionic in 
nature. The association constants for Zn^ and Mn^ are 6  and 5 orders of 
magnitude less than for Cu^ respectively. Despite this relatively low binding 
affinity, two thirds of the plasma Zn^ not already bound to a 2 -macroglobin is found 
bound to HSA. Mercury binds to the thiol group of residue Cys-34 and Sarkar et al 
(1983) found that a dimer of albumin was formed through binding to one Hg^ ion. 
Gold also binds to HSA with some sort of association with the thiol group of Cys- 
34.
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1.12 Glycation of HSA
1.12.1 Sites of glycation of HSA
In  vivo the principal site of glycation is Lys-S2S, which is in domain m . Nearly half of all in 
vivo glycation occurs at this residue. This was determined by treating in vivo glycated HSA 
with NaB^H4  followed by tryptic digestion. The glycated fragments were then adsorbed to 
an Affi-Gel 601 boronic acid affinity column and the glycated residue Lys-525 was 
identified. This lysine residue is the second or carboxyl lysine of a lysine-lysine sequence 
[Garlick and Mazer, 1983]. The first lysine is thought to catalyse the rearrangement of the 
Schiffs base to the Amadori product by acid catalysis. At least a fiirther 8  of the 59 lysine 
residues in HSA are glycated in vivo. The three lysine residues which are most often 
glycated after Lys-525 are Lys-439, Lys-281, and Lys-199. Lys-233, Lys-317, Lys-12 and 
Lys-534 are also glycated in vivo, but to a lesser extent [Iberg and Fliickiger, 1986].
In  vitro, residue Lys-199 is the principal site of glycation. This residue is on the 
interdomain peptide between domains I  and I I  [Carter et al, 1989]. Glycation starts with 
nucleophilic attack by an unprotonated amine group on a glucose (or other reducing sugar) 
in its straight chain form. The product of this reaction is a Schiffs base. At physiological 
pH very few primary amino groups are unprotonated. The pK of Lys-199 is thought to be 
8.0-8.7 whereas other lysine residues in HSA have much higher pK values which are in the 
region of 11. Lower pK values of lysine residues favour both the formation of the Schiffs 
base and its subsequent rearrangement to the Amadori product, as both o f these reactions 
can only proceed when the amino group is uncharged [Iberg and Flückiger, 1986; Garlick 
and Mazer, 1983].
The pK of the amino group is not the only factor which determines which lysine residue is 
glycated, because despite having a more unfavourable pK value than Lys-199, Lys-525 is 
glycated in preference to Lys-199 in vivo. A possible explanation for this is that Lys-199 is
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sterically hindered by fatty acids or other large molecules which would prevent the sugar 
molecule from reaching the amino group. These large molecules may be inadvertently 
removed from the HSA during the purification process which precedes any in vitro work 
[Garlick and Mazer, 1983]. Murtiashaw and Winterhalter (1986) showed that ^ycation of 
albumin up to 3 moles of glucose per mole o f protein did not affect the binding of palmitate 
to HSA, even though the residue Lys-525 has been implicated as being in the primary fatty 
acid binding site
The formation of Schiffs base is a reversible process, so if  conditions are unfavourable for 
the Amadori rearrangement to proceed, then much of the Schiffs base formed at that residue 
will dissociate before the reaction sequence can continue. This could explain why the 
choice of glycation site is not solely dependent on the pK of the lysine residue. The 
Amadori product is much more stable than the Schiffs base, but the Amadori rearrangement 
is also a reversible process which can be accelerated by acid-base catalysis (see Section 1.2).
Glucose uptake in vitro is fastest in the first two days of incubation, after which the rate of 
glucose incorporation decreases. This could be because most readily glycated sites 
becoming used up in the first two days [Mereish et al, 1982]. Mereish also found that the 
rate and extent of glycation of HSA are both increased when fatty acid molecules are 
removed from HSA, and that the initial rate of glycation is much higher in delipidated HSA 
than in native HSA. However, the delipidated HSA used by Mereish was prepared by 
heating at very low pH which may have caused the hydrolysis of Amadori products already 
on the protein. The total amount of Amadori product present on each of the forms of HSA 
was not recorded, because he measured the uptake of radioactive glucose. HSA is not 
denatured by the charcoal method of delipidation [Chen, 1967], and it was this preparation 
which was used in my work.
It has been shown that the main in vitro site of glycation is Lys-199, instead of Lys-525 
which is the mmn site o f glycation in vivo. Lys-199 is also the binding site for salicylate and 
it has been observed that the glycation of this residue interferes with the binding of
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salicylate. In binding studies it has been shown that glycated HSA has only one class of 
salicylate binding site, whereas partially and non glycated HSA have two classes of binding 
site for salicylate [Mereish et al, 1982]. It has also been suggested that up to 25-30% 
glycation of HSA there is no appreciable decrease in salicylate binding to HSA. The 
accepted figure for glycation of HSA in diabetics is 25-30%, so it is unlikely that there is 
any impmrment of salicylate binding in vivo [Mereish et al, 1982].
1.12.2 Extent of glvcation of in vivo HSA
The extent o f glycation of HSA in normal indmduals is between 10% and 12% when phenyl 
boronic acid affinity gel is used to separate glycated from non-glycated HSA. However, it 
has been shown that HSA glycated at the e-amino lysine residue is not completely retained. 
The proportion of glycated HSA bound to the phenyl boronic acid affinity resin varies with 
the chromatographic conditions, and the normal values for the percentage of HSA 
molecules reflect this (estimates vary between 6.3% and 15.5%) [Schleicher and Wieland, 
1989]. When HPLC is used the normal value for percentage of HSA glycated is 20% 
[Schleicher and Wieland, 1989]. This value of 20% is still low compared to the 25% which 
is found when cheinical assays are used [Baynes et al, 1984]. One explanation for this 
discrepancy could be that some molecules will be multi-glycated (i.e. have more than one 
bound sugar residue) and the chromatography methods will count the protein molecule only 
once, whereas the chemical methods will measure each sugar molecule which is covalently 
bound.
The value of 25% glycation of HSA in vivo is much higher than the in vivo value for 
haemoglobin which is 7.5% [Olufemi et al, 1987]. Unlike haemoglobin, which is principally 
glycated at the N-terminal valine of the P-chain (alpha glycation), albumin is glycated at the 
8 -amino groups of certain lysine residues, and little alpha glycation has been shown to 
occur, although Olufemi et al (1987) suggest that a small amount of HSA glycation does 
occur at the N-terminal.
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1.12.3 Recombinant HSA
A sample of recombinant HSA was provided by Delta Biotechnology Ltd., enabling me to 
carry out investigations on samples of HSA that had well defined lipid content. 
Recombinant HSA has been synthesised in brewers yeast (by gene insertion) and extracted 
and renatured. The properties of this protein are very similar to those of native HSA, 
although there are slight differences in bilirubin binding curves, and spectra have shown that 
some uv absorbing nonrprotein impurities are present in recombinant HSA. The metal 
chelator EDTA is included in the buffers at every step of the extraction and purification 
processes, so recombinant HSA has a very low Cu^ content [Quirk et al, 1989]. The lipids 
that are bound to recombinant HSA are 97.6% saturated and 2.4% unsaturated, with only 
0.01% of the total fatty acids being polyunsaturated [Delta data sheet].
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1.13 Transferrin
Transferrin was used in some of these studies because it is an iron binding protein which 
complements the use of the copper binding protein HSA. Human transferrin is a single 
chain polypeptide o f678 amino acid residues and a molecular weight of 79,550 daltons.
This includes the two Asn linked glycan moieties each of molecular weight 2207 
[MacGillivray et al, 1982]. Transferrin reversibly and strongly binds two iron atoms per 
molecule. Transferrin fimctions mainly as an iron-transport protein, although it is also 
believed to play a role in protection against micro-organisms by denying them the iron they 
need to grow. It is found mainly in the extracellular fluid and the serum. Its serum 
concentration is 2-4 mg/ml and it is usually about 30% iron saturated in vivo [Brock, 1985]. 
Iron is not an inherent part of transferrin so the protein can fold correctly in the absence of 
iron [Bailey et al, 1988].
The transferrin molecule is ellipsoidal in shape with the ratio of major to minor axes 3:1 in - 
the case of the apoprotein, and 2.5:1 when the protein has two iron ions bound. The 
polypeptide chain is folded into two lobes which are held by 19 disulphide bridges, 8  of 
which are in the N-terminal lobe and 11 in the C-teiminal lobe [Bailey et al, 1988; Brock, 
1985]. Both the glycan moieties are on the less flexible C-terminal lobe, and are joined 
through 13-N-glycosidic linkages to asparagine residues 415 and 608 [Aisen and Listowsky, 
1980]. The two lobes have a large amount o f amino acid homology, and when their 
sequences are compared it is found that 40% of the residues are identical, whilst many of 
the non-identical amino acid residues have been replaced by amino acid residues with similar 
chemical properties [MacGillivray et al, 1982]. A short polypeptide chmn joins the two 
lobes and is a maximum of 7 residues long, as it falls between the half-cystine residues at the 
end of each lobe [MacGillivray et al, 1982].
Each lobe consists of two dissimilar domains, with the iron-binding site for each lobe being 
at the domain interface. The binding and release of iron at the binding site involves . 
movements of the domains which open and close the binding cleft [Baker and Lindley,
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1992]. The binding of metal appears to stabilise the structure of the transferrin molecule as 
the metal-loaded protein is more resistant to thermal and proteolytic attack than the 
apoprotein [Aisen and Listowsky, 1980]. The binding sites for the iron ions are estimated 
as being 25-43A apart [Heubers and Finch, 1987]. The iron binding cleft in both the C- 
terminal and N-terminal lobes contains a lysine residue (Lys-206 in the N-terminal cleft and 
Lys-534 in the C-terminal cleft). These appear to play no part in the co-ordination of the 
iron ion to transferrin, although both undergo a large change in reactivity on the binding of 
iron to apotransferrin [Bailey et al, 1988].
In the absence of iron, transferrin will bind other metals in vitro including gallium, copper, 
chromium, cobalt, manganese, vanadium, aluminium, europium, plutonium and platinum, 
but all these metals are displaced from the specific binding clefts by iron. In  vitro binding of 
these metals should not be taken as evidence of in vivo binding. In  vivo, even though there 
are metal binding sites available on transferrin and serum copper levels are similar to serum 
iron levels, no appreciable amount of copper is found bound to transferrin. Although 
transferrin can bind Zn^ in vitro, it is unlikely to be bound to transferrin in serum, as HSA 
is present at high concentrations and binds Zn^ with a much greater affinity than transferrin 
[Heubers and Finch, 1987; Brock, 1985]. More than two equivalents of Cu^ and Zn^ can 
be bound to transferrin although only the first two ions to bind are bound with high affinity 
[Brock, 1985]. Human serum transferrin has 19 histidine residues which may play a role in 
the non-specific binding of these metal ions [Hudson et al, 1972].
Transferrin incubated with 20mM glucose for seven days forms 1.1 moles of Amadori 
product per mole of protein [Ney et al, 1985]. Glycation of transferrin did not affect the 
rate or extent of iron binding, therefore it seems unlikely that either Lys-206 or Lys-534 
(the lysine residues found in each of the iron binding clefts) are involved in the formation of 
Amadori product [Ney et al, 1985; Bailey et al, 1988]. In  vivo, transferrin has 1.32 moles 
of Amadori product per mole o f protein compared to 3.44 moles o f Amadori product per 
mole of H SA . The half-life of transferrin is 8.5 days as opposed to 19 days for HSA 
[Zoppi et al, 1987], which may explain its lower glycation in vivo.
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1.14 Inhibitors of AGE formation
It has been shown by many groups that the addition of metal chelators to in vitro  ^ ycation 
media inhibits the production of fluorescent AGEs, glucose-derived crosslinks and glucose- 
induced protein fragmentation [Fu et al, 1992; Hunt et al, 1988a]. These compounds 
include DTPA [W olff and Dean, 1987; Fu et al, 1992], EDTA [W olff and Dean, 1986] and 
desfenioxamine [Le Guen et al, 1992]. It has been shown by Fu et al (1992) that the metal 
chelator DTPA inhibits the formation of AGEs, but does not affect the formation of the 
Amadori product. Amadori product formation is also unaffected by the absence of oxygen 
during the reaction, although AGE formation does not occur under anaerobic conditions. 
Clearly the use of metal chelators and anaerobic conditions are only of use for in vitro 
studies, and therefore other potential inhibitors of the Maillard reaction for use in vivo have 
been investigated. A brief outline of the four potential inhibitors used in this study is given 
below.
1.14:1 Aminoguanidine
Aminoguanidine is a nucleophilic hydrazine with three amino groups (Figure 1.5). It was 
first used in 1986 [Brownlee et al] when it was found to inhibit fluorescence but not the 
formation of Amadori products. It has been reported that aminoguanidine inhibits the 
covalent attachment of radio labelled sugars to lens proteins [Lewis and Harding, 1990]. 
Recent work by Requena et al (1993) has investigated more thoroughly the mechanism by 
which aminoguanidine inhibits AGE formation. Both the fhictosamine and furosine assays 
were used to monitor Amadori product formation. Including aminoguanidine in the 
incubation medium did not reduce the amount of Amadori product formed. However, at 
high concentrations of aminoguanidine, the fiiictosamine assay gave a lower reading whilst 
the fiirosine assay gave a constant reading, which demonstrates blocking of Amadori groups 
by aminoguanidine (See Section 1.10). Inhibition of fluorescence formation occurs at low
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concentrations of aminoguanidine, showing that it is not due to either aminoguanidine 
reacting directly with the glucose or the blocking of Amadori groups by anunoguanidine, as 
this is only seen at high concentrations of the inhibitor. This suggests that aminoguanidine 
acts on a post-Amadori intermediate of the Maillard reaction. This agrees with earlier work 
carried out by Oimomi and Igaki (1989) in which aminoguanidine inhibits the in vitro 
development of fluorescence and crosslinks in proteins incubated with the post-Amadori 
dicarbonyl intermediate 3-deoxyglucosone. It has been postulated that 3-deoxyglucosone 
plays a large role in the development of AGEs [Kato et al, 1989].
1.14.2 Propvl Gallate
Propyl gallate is a synthetic antioxidant which like trolox is based on an aromatic ring 
(Figure 1.5). It prevents the propagation of radical reactions by donating a proton to 
radicals such as the peroxyl and alkoxyl radicals, forming a radical stabilised by 
delocalisation around the aromatic ring. This new radical is not sufficiently reactive to 
abstract further protons to propagate the reaction. The action of propyl gallate may be two­
fold as it is also capable of binding transition metal ions which may prevent them from 
catalysing oxidative reactions. It is a water-soluble compound which is often added to 
foodstuffs as an antioxidant [Halliwell and Gutteridge, 1989].
1.14.3 Trolox
Trolox is a water-soluble vitamin E derivative (Figure 1.5). Vitamin E is probably one of 
the major fat-soluble antioxidants found in vivo. It is a very efrective inhibitor of lipid 
peroxidation reactions as it can donate a proton to peroxyl or alkoxyl radicals and prevent 
propagation of the reaction [Halliwell and Gutteridge, 1989]. Vitamin E reduces glycation 
of HSA as measured by phenyl boronic acid affinity chromatography in a dose-dependent
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manner [Ceriello et al, 1988]. Vitamin Ë has also been shown to be an effective inhibitor of 
lipid peroxidation induced by a glycated polylysine-iron complex [Sakurai et al, 1991].
1.14.4 Acetvl Salicvclic Acid
Acetyl salicyclic acid (or aspirin) is capable of acetylating proteins at the amino groups, thus 
blocking the formation of Amadori products. It was suggested by Cotlier and Sharma in 
1981 from epidemiological studies, that acetyl salicyclic acid plays a protective role against 
the formation of diabetic cataracts. In  vitro the inhibition of glycation corresponds to a 
reduction of aggregate formation in lens proteins, possibly because the acétylation of lens 
proteins causes less unfolding and aggregation of the proteins than glycation [Swamy and 
Abraham, 1989] . The structure of acetyl salicyclic acid is shown in Figure 1.5.
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NH1
H2N —  NH"^NH2 OH
Aminoguanidine Propyl Gallate
COOH
COOH
CH]
Trolox Acetyl Salicyclic Acid
Figure 1.5: Structures of aminoguanidine, propyl gallate, trolox and acetyl salicyclic acid
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1.15 Aims
In order for effective drug therapy for diabetic complications to be developed a better
understanding of the reactions involved in the formation o f AGEs is needed. Using
fluorescence spectroscopy and gel electrophoresis the aims of this project were:
i) to show that the changes observed in proteins incubated with sugars are in fact due to 
reaction of the protein with sugar rather than other reactions that occur with the 
ageing of proteins,
ii) to see the effect that the bound lipid on albumin has on the formation of Amadori 
product and on the post-Amadori reactions of glycofluorophore formation and protein 
fragmentation,
iii) to determine the role that transition metals play in the formation of glycofluorophoresd 
and the fragmentation of proteins, and to investigate whether the specific binding of 
transition metals to proteins influences these reactions,
iv) to elucidate the mechanism of these reactions by using inhibitors and to determine 
whether or not the products of glucose oxidation reactions are involved in the 
formation of AGEs.
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METHODS
2.1 In  vitro incubations of proteins with glucose
Proteins were incubated at concentrations of 1,10,20 and 40 m^ml with various 
concentrations of sugars (usually glucose). Most of the incubations were in sodium 
phosphate buffer of pH 7.4 although in certain experiments HEPES buffer (also pH 7.4) 
was used. Sodium azide (3mM) was included in the incubations to prevent bacterial 
contamination. All incubations were at 37°C. At the end of the incubation period, 
samples were frozen to stop the reaction from proceeding any further.
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2.2 Measurement of the extent of glvcatîon
Samples to be assayed for Amadori product were dialysed extensively against 0.05M  
sodium phosphate buffer, pH 7.4, using a membrane with a molecular weight cut-off of 
12000-14000 daltons. This was done to remove free sugars which interfere with the 
periodate assay.
2.2.1 Periodate Assav
An adaptation of the microplate version [Ahmed and Furth, 1991] of the periodate assay 
devised by Gallop et al (1981) was used.
Duplicates of all samples and standards were run throughout this assay. 60pl o f each 
sample was placed in a microcentrifuge tube and 30pl each of 0 . IM  HCl and O.SM NalO^
were added to each tube. The tubes were vortexed and allowed to stand at room 
temperature for 30 minutes before being placed on ice for 10 minutes to stop the 
oxidation reaction. Pre-cooled 15%ZnS0^ (30pl) and 0.7MNaOH (30pl) were added to
each tube. The tubes were vortexed and then centrifuged immediately at 12000rpm for 
15 minutes using a Heraeus Biofuge A. lOOpl of the supernatant from each sample or 
standard were put into the wells of a microplate and 2 0 0 pl of formaldehyde detection 
reagent was added to each well. The microplate was mixed using a Wellmixx 1, and then 
covered and incubated at 37°C for 1 hour. The plate was allowed to cool to room 
temperature for 10 minutes before the absorbance at 405nm was read using a Microplate 
reader (Bio-tek EL311). Formaldehyde detection reagent was prepared fresh every time 
by dissolving 2.54g of ammonium acetate and 46pl of acetylacetone in water with a final 
volume o f 1 0 ml. A full set of fructose standards were run with every set o f samples as 
this assay is both temperature and time dependent.
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2.2.2 Protein Détermination
The concentration of protein in sang)les after dialysis had to be determined in order to 
calculate the number of moles of Amadori product formed per mole of protein. This was 
measured using the Pierce BCA protein assay reagent (Prod no. 23225). Copper binds to 
the peptide bonds of proteins and under alkaline conditions the peptide-bound copper(II) 
w ill react to form copper(I). It is the peptide-bound coppei(I) that reacts with 
bicinchoninic acid to produce the intense purple colour. The protocol provided by the 
manufacturer of this kit was followed and the absorbance was measured at 57Qnmusing 
the microplate reader. A  standard curve was run every time as this assay is both 
ten^erature and time dependent.
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2.3 Measurement of AGEs
Both glycofluorophore production and the glucose-induced fragmentation of proteins 
were measured as part of the project.
2.3.1 Measurement of fluorescence
During the course of this study, three different fluorimeters were used. Initial 
fluorescence readings were carried out using an Aminco Bowman Spectrofluoiimeter 
(model J4-8960). In later work both the Perkin Elmer LS30 and LS50B were used.
(i) IJsinp the Am inco Bowm an Spectroflunrim eter
Sandies were diluted to a concentration of lp,M protein with water and the fluorescence 
measured at excitation 325 and emission 375nm. Quinine sulphate standards inO.lM H^ 
SO4  read at excitation 250nm and emission 45Qnm were used to calibrate the fluorimeter 
on a daily basis. The emission slit was 1mm and the excitation slit was 2 mm All sangles 
were read in duplicate and were expressed as relative fluorescence. Unfortunately the 
xenon lan^ in the fluorimeter was ageing and the fluorescence readings of the quinine  ^
sulphate standard was decreasing in value. This made it impossible to directly compare 
values obtained in early experiments with later experiments, although within each section 
of this thesis the results are always directly comparable. The same trends are always seen 
in duplicate experiments even if  the absolute values could not be superimposed on earlier 
work. When a suitable replacement lamp was found, the power supply was no longer 
dehvering a smooth current. Depite the efforts of technical staff at the Unit it was not 
possible to correct this fruit making it necessary to find alternative equipment to finish 
this work.
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(ii) Perkin Elmer LS30
A Perkin Elmer LS30 was kindly lent to us by Perkin Elmer whilst the purchase of a new 
fluorimeter was being arranged. It was not as sensitive as the Aminco Bowman had been 
so a higher concentration of protein in each sample was used (O.Smg/ml or 7.2pM of 
HSA). Fluorescence readings were recorded at both excitation 325nm/emission 37Snm 
and excitation 370nm/emission 440nm for duplicates of all samples. Quinine sulphate 
standards were used to calibrate the fluorimeter and unlike the Aminco Bowman these 
values remained steady from day to day for both standards and samples. All samples 
were measured in a flow cell as there is no facility to use cuvettes with this model.
(iii) Perkin Elmer LSSOB
Samples were read at a concentration of 0.5mg/ml in this fluorimeter. Unlike the LS30 
model either a cuvette or flow cell could be used. The LSSOB also enabled me to scan 
fluorescence and take second derivatives of the spectra, which neither of the other two 
machines were capable of. The daily calibration of this machine with quinine sulphate 
showed that it held a constant value from week to week.
2.3.2 Detection of protein fragmentation
Vertical gel electrophoresis was performed according to the method o f Laemmli (1970) 
using 10% gels. However, piperazine diracrylamide (PDA - Bio rad cat no. 161-0202) 
was used in the place of bis-acrylamide in order to reduce the background in silver stained 
gels. The gels were run at a constant voltage of 175 V  for approximately 1 hour in a Bio­
rad mini-PROTEAN II  apparatus. Gels were stained using the Bio-rad Silver stain Plus 
kit (Cat no. 161-0449).
Samples were boiled in 2x buffer for three minutes prior to loading onto the gel, and 
approximately l-2pg of protein in a volume of 5pl was added to each well. The 
composition of the 2x buffer is 0.125M Tris-HCl, pH 6 .8 , 4% SDS, 20% glycerol, 10%
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2-mercaptoethanol and 0.002% bromophenol bhie. Molecular weight marker kits from 
Bio-rad and Sigma with molecular weight ranges of 14-97kD and 14.2-66kD were used. 
In addition to these molecular weight standards lysozyme was added to some of the 
protein sanqxles, immediately prior to treatment with the 2x buffer, in order to provide an 
internal standard. A  band of approximately 45kD was observed, which is due to the 
presence of ovalbumin in the lysozyme supplied by Sigma.
In some cases, e.g. Figure 3.1.4, fragmentation is seen as a loss of starting material and/or 
a non-discreet smear of lower molecular mass, whilst in other cases, e.g. Figure 3.4.6, a 
series of discreet lower molecular weight bands can be seen.
The exact conq>osition of the gels is shown in Table 2.1.
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Table 2.1 : Composition of Gels
Resolving Gel (10%) Stacking Gel (4%)
Acrylamide/PDA Stock 3.33 ml 0.65 ml
Water 4.02 ml 3.05 ml
1.5M Tris-HCl pH 8.8 2.5 ml 0
0.5M Tris-HCl pH 6.8 0 2.5 ml
10% SDS 100 ul SOjll
10% Ammoniumjxersulphate lOOul sow
TMED 15 ul lo w
The acrylamide/PDA stock solution had 30% acrylamide and 2.67% PDA. The 
composition of the running buffer was 0.025M Tris, 1.92M glycine and 1% SDS adjusted 
to pH 8.3.
Gels were photographed using type 53 Polaroid film in a Polaroid camera (Model MP-4) 
fitted with a green filter (no. 58).
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2.4 Source of proteins
Fraction V  native and delipidated HSA were both obtained from Sigma Chemical 
Company Ltd. (prod no. A 1653 and A 1887). The delipidated HSA was prepared by the 
method of Chen (1967), which uses charcoal to remove the lipid without denaturing the 
protein. Both forms of HSA were only 96 to 99% pure according to the manufactureras 
details, although no impurities showed when these proteins were stained with Coomassie 
Blue on SDS-PAGE. However, where silver staining is used with SDS-PAGE these 
impurities can be seen.
The recombinant HSA was a gift from Delta Biotechnology Ltd. and has low levels of 
bound copper and polyunsaturated lipids [Quirk et al, 1989].
Transferrin was obtained from Sigma Chemical Company Ltd. (prod no. T 4515) and by 
the manufacturers analysis was approximately 95% pure.
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RESULTS
3.1 Glucose dependency of AGE formation
At the start of this project some experiments were carried out to determine whether 
fluorescent products similar to AGEs form on proteins without the presence of reducing 
sugar in the incubation media. Figures 3.1.1, 3.1.2 and 3.1.3 show that under the 
conditions used for the incubations, little or no fluorophore production at excitation 
325nm and emission 375nm occurs unless glucose is present. Similar experiments were 
carried out to determine the role glucose plays in the fragmentation of proteins. Figure
3.1.4 shows that no fragmentation of protein occurs under the incubation conditions used 
unless glucose is present in the incubation. Lanes A and B contain native and delipidated 
HSA respectively, incubated in the absence of glucose and lanes C and D contain the 
same proteins incubated under identical conditions except for the inclusion of glucose. 
Fragmentation of the protein is only seen in lanes C and D.
The results in all figures referred to above, and in the sugar-free controls run alongside 
the other experiments throughout this project, show that under the conditions used, no 
fluorescence forms and no fragmentation occurs unless a reducing sugar such as glucose 
is present in the incubation. Therefore, it is possible to follow the formation of AGEs 
without interference from changes in the protein that occur in the absence of sugars.
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Figure 3.1.1: Fluorescence o f native HSA incubated with glucose.
Fluorescence at excitation 325nm and emission 375nm of native HSA incubated at 
lOmg/ml in 0.2M sodium phosphate buffer (pH 7.4) with glucose (500mM).
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Figure 3.1,2: Fluorescence of delipidated HSA incubated with glucose.
Fluorescence at excitation 325nm and emission 375nm o f delipidated HSA incubated at 
lOmg/ml in 0.2M sodium phosphate buffer (pH7.4) with glucose (SOOmM).
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Figure 3.1.3: Fluorescence o f recombinant HSA incubated with glucose. Fluorescence 
at excitation 325nm and emission 375nm o f recombinant HSA incubated at lOmg/ml in 
0.2M  sodium phosphate bufifer(pH 7.4) with glucose (500niM).
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Figure 3.1.4: Fragmentation of native and delipidated HSA incubated with glucose. 
Native and delipidated HSA incubated in O.IM sodium phosphate buffer (pH7,4) for 8 
days at 37°C in lanes A and B. Lanes C and D include 250mM glucose in the incubation.
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3.2 Effect of protein-bound lipid on the production 
of Amadori product and AGEs in albumin
The following set of experiments were carried out to determine whether the presence o f 
bound lipid on albumin affected the formation of Amadori product, AGE-type 
fluorescence and glucose-induced protein fragmentation.
3.2.1 Effect o f bound lipid on Amadori product formation
Figure 3.2.1 shows the production of Amadori product on both native and delipidated 
HSA incubated in 0.05M sodium phosphate buffer, pH7.4 (containing 3mM sodium 
azide). Glucose was included in the incubation media at concentrations o f 0, 50, 100,
200, 300, 400 and SOOmM and the incubations were carried out at 37°C over a period of 
8 days. The samples were dialysed extensively in the phosphate buffer used in the 
incubation to remove all unbound glucose, before protein and periodate assays were 
carried out to determine the number of moles of Amadori product per mole of protein. 
There appears to be a slight difference between the two forms of HSA in the formation of 
Amadori product, but the difference is not significant.
3.2.2 Effect o f bound fatty acid on fluorescent AGE formation
Figure 3.2.2 shows the relative fluorescence of native, delipidated and recombinant HSA 
all incubated in 0.2M sodium phosphate buffer (with 3mM NaNg) at a concentration of 
10 mg/ml in the presence and absence of glucose (SOOmM). It shows that the 
delipidation of HSA, prior to incubation with glucose, reduces the amount o f fluorophore 
formation during these incubations, even though the starting values for relative 
fluorescence for native HSA in both its native and delipidated states are very similar. The
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delipidated HSA only forms approximately 40% of the amount o f fluorescence formed by 
native HSA when both proteins are incubated under identical conditions. The 
recombinant HSA has bound lipid of known composition in which a greater proportion of 
lipids are saturated and shorter chained than those found on native HSA, and it only 
forms approximately 80% of the fluorescence of native HSA. Even when bound lipid is 
present on HSA no increase in fluorescence is seen unless glucose is present.
3.2.3 Effect o f bound fattv acid on protein fragmentation
In Figure 3.2.3 both native and delipidated HSA are incubated under identical conditions 
and then examined by SDS-PAGE. It can be seen that for each set o f conditions used the 
fragmentation patterns for both forms of HSA are identical showing that glucose induced 
fragmentation o f HSA is unaffected by the presence o f bound lipid on the protein. When 
both glucose and Cu" are present in the incubation media there is a decrease in the 
intensity o f the 66kD band and there is staining around the 2 6 -3 0  and 15kD areas for 
both forms o f HSA, although the staining of these fragments is very diffuse.
Dog serum albumin (DSA) was included in this study because it has not got the single 
high affinity binding site for Cu" that is present in HSA. However, the only difference 
observed in the behaviour o f DSA compared to HSA, was with respect to its bound lipid. 
Figure 3.2.4 shows the extent of fragmentation o f native and delipidated DSA that has 
been incubated under identical conditions. The fragmentation of the two forms o f DSA is 
very similar to each other except when glucose and Cu^  ^are added to the incubation 
(lanes D and H respectively). Delipidated DSA fragments to a greater extent than native 
DSA as judged by the decrease in intensity of the 66kD band and an increase in smearing. 
Both the native and delipidated DSA produce a fragment of approximately 26 - 30kD 
and like the fragments found in Figure 3.2.3 it appears as a diffuse band.
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3.2.4 Aggregation
Incubating native HSA in the presence of FeClg (Figure 3.4.12) produces no
fragmentation but it does appear to promote the production o f high molecular mass 
oligomers. This effect is only seen for HSA with bound lipids, i.e. native HSA. No 
increase in high molecular mass substances is seen in the incubation o f delipidated HSA 
(Figure 3.4.13).
3.2.5 Direct incubation of fattv acid with protein and glucose
Direct incubation o f native BSA with lipid and glucose was attempted following work 
carried out by Birrulez-Aragon et al (personal communication). Native BSA was 
incubated at 40°C with linoleic acid at a ratio o f 10 moles o f lipid per mole o f BSA, and 
the fluorescence at 325/375 and 370/440 was followed. After incubation for 78 minutes 
the glucose concentration was increased to 250mM to see whether the higher glucose 
concentration would cause an increase in fluorescence. After 160 minutes the incubation 
was halted as no appreciable increase in fluorescence was observed and it was seen that 
the lipid was no longer mixing with the protein, but was floating on top o f the incubation 
media.
3.2.6 Summarv
The results ifom Sections 3.2.2 and 3.2.3 indicate that the mechanisms for the formation 
o f AGE-type fluorescence and for the glucose-induced fragmentation o f HSA are 
different. The fatty acids bound to HSA appear not to affect the fragmentation o f the 
protein at all, but the delipidated HSA only produces approximately 40% of the amount 
o f fluorescence produced by HSA with bound fatty acids under the conditions used in 
these experiments. However, if a HEPES buffer system is used instead of phosphate
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there is very little difference between the amount of fluorophore production by the 
different forms o f HSA (see Section 3.5, Figure 3.5.4). In DSA, unlike HSA, the 
presence o f bound lipid does affect the fragmentation o f the protein with the delipidated 
DSA being fragmented to a greater extent than native DSA. The production o f Amadori 
product on HSA does not appear to be affected by the presence o f bound lipids.
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Figure 3.2.1: Production of Amadori product in native and delipidated HSA.
Native and delipidated HSA were incubated with glucose (0, 50, 100, 200, 300, 400 and 
SOOmM) for 8 days in 0. IM sodium phosphate buffer.
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F igure 3.2.2: Fluorescence of native, delipidated and recombinant HSA. 
Fluorescence at excitation 325nm and emission 375nm o f native, delipidated and 
recombinant HSA ail incubated at lOmg/ml in 0.2M sodium phosphate buffer, pH 7.4, 
with glucose (SOOmM).
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Figure 3.2.3: Fragmentation of native and delipidated HSA incubated with glucose, 
copper and DTP A. Lanes B and C show native and delipidated HSA incubated for 8 
days at 37°C in O.IM sodium phosphate buffer (pH7.4) respectively. Lanes D and E show 
the effect o f glucose (25mM), lanes F and G show the effect o f glucose and CuSO^ 
(lOOpM), and lanes I and J show the effect of glucose and DTP A (ImM), on the two 
forms of HSA.
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Figure 3.2.4: Fragmentation o f native and delipidated DSA incubated with glucose, 
copper and DTPA. Native DSA (lanes A, C, D and E) and delipidated DSA (lanes 
F,G,H,I and J) were incubated for 8 days at 37°C in O.IM sodium phosphate buffer, 
pH7.4, with glucose (25mM) in lanes C and G, with glucose and CuSO^ (100|iM) in 
lanes D and H, with glucose and DTPA (ImM) in lane I and with CuSO^ (lOOpM) in 
lanes E and J.
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3.3 Effect o f trace transition metals on AGE formation
Traces of the transition metals copper and iron are present even in high grade 
preparations o f sodium phosphate buffers. It was therefore decided to determine whether 
these contaminants play a role in the production of AGEs by using the metal chelator 
diethylenetriaminepentacetic acid (DTPA).
3.3.1 Fluorescence
The transition metal chelator DTPA was added to the incubation media to test whether 
traces o f transition metals in the incubation media were catalysing the development of 
fluorescent AGEs. Figures 3.3.1, 3.3.2 and 3.3.3 show the effect of adding DTPA 
(ImM) to the incubation media used in Figures 3.1.1, 3.1.2 and 3.1.3. The glucose-free 
controls for each of the three forms of HSA appear as virtually identical traces whether 
DTPA was present in the media or not. The presence o f DTPA reduces the amount of 
glycofluorophore formation compared to when the proteins are incubated with glucose 
alone. The inhibition of fluorescence formation was 88% for native HSA, 100% for 
delipidated HSA and 63% for recombinant HSA when DTPA was present at a 
concentration of ImM. The approximate concentration of transition metal contaminants 
in the phosphate buffer as calculated from the suppliers analysis are 4pM  Cu^^and 5pM 
Fe"^. All solutions were made with high quality distilled water, so that any additional 
transition metal contaminants from this source were at such low concentrations that the 
metal chelator DTPA was in very large excess.
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3.3.2 Fragmentation
Fragmentation gels o f transferrin, native HSA, delipidated HSA, native DSA and 
delipidated DSA ail incubated in the presence of glucose with and without DTPA show 
that DTPA in the incubation media can inhibit the fragmentation o f all o f these proteins. 
Figure 3.3.4 shows the effect o f DTPA on the fragmentation o f both native HSA and 
delipidated HSA. Lanes D and E show both native and delipidated HSA incubated with 
glucose, and lanes I and J show the same samples with DTPA also included in the 
incubation. The samples incubated with DTPA appear to be very similar to the glucose 
free controls run in lanes B and C. In lanes D and E there in a marked decrease in the 
intensity o f the 66kD band relative to the 45kD marker band intensity, showing that 
protein fragmentation is occuring in the presence of glucose unless DTPA is present. The 
inhibition o f protein fragmentation by DTPA is not confined to HSA. Both transferrin 
(Figure 3.4.6 - lane E) and DSA (Figure 3.2.4 - lane I) show complete inhibition of 
protein fragmentation when DTPA is included.
3.3.3 Summarv
Both the fluorescence and fragmentation results show that AGE production is inhibited 
by the presence o f DTPA, showing that these reactions are transition metal catalysed. 
However, the inhibition o f fluorescence formation in recombinant and native HSA is not 
100% under the conditions used, although there is 100% inhibition o f fluorophore 
production in the delipidated HSA.
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Figure 3.3.1: Fluorescence of native HSA incubated with glucose and DTPA. 
Fluorescence at excitation 325nm and émission 375nm o f native HSA incubated at 
lOmg/ml in 0.2M sodium phosphate buffer (pH 7.4) with glucose (SOOmM) and DTPA 
(ImM).
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Figure 3.3.2: Fluorescence o f delipidated HSA incubated with glucose and DTP A. 
Fluorescence at excitation 325nm and emission 375nm of delipidated HSA incubated at 
lOmg/ml in 0.2M sodium phosphate buffer (pH 7.4) with glucose (SOOmM) and DTP A 
(ImM).
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Figure 3.3.3: Fluorescence of recombinant HSA incubated with glucose and DTPA. 
Fluorescence at excitation 325nm and emission 375nm of recombinant HSA incubated at 
lOmg/ml in 0.2M sodium phosphate buffer (pH 7.4) with glucose (SOOmM) and DTPA 
(ImM).
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Figure 3.3.4: Fragmentation of native and delipidated HSA incubated with glucose and 
DTPA. Native and delipidated HSA were incubated at Img/ml in O.IM sodium 
phosphate buffer, pH 7.4, at 37°C for 8 days. Lanes B and C show native and delipidated 
HSA incubated in buffer, Lanes D and E the effect o f glucose (250mM),and lanes F and 
G show the effect DTPA (ImM) and glucose (250mM) have on the fragmentation o f the 
two proteins respectively.
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3.4 Effects o f the transition metals Culland FeH on AGE formation
Traces o f the both Cu" and Fe^“ (approximately 4)aM and 5|aM respectively) are found in 
the 0. IM  sodium phosphate buffer used in earlier experiments. The inclusion o f DTPA in 
this buffer system inhibits the formation of AGEs so the effect o f adding further quantities 
o f each o f these metals was investigated.
3.4.1 Effect o f Cu" on AGE fluorescence formation
Figure 3.4.1 shows native, delipidated and recombinant HSA incubated under identical 
conditions to Figure 3.2.2 (i.e. with SOOmM glucose), apart from the inclusion o f SO|aM 
CUSO4 in the incubation media. By comparing these two figures, it can be seen that 
adding copper has no effect on the fluorescence o f native or delipidated HSA, but 
enhances the fluorescence of recombinant HSA.
Figures 3.4.2, 3.4.3 and 3.4.4 show the fluorescence of native and delipidated HSA and 
transferrin all incubated at 1 mg/ml in O.IM sodium phosphate buffer (pH7.4) at 37°C for 
8 days with glucose (2SmM) and increasing concentrations of CuSO^ (0, 10, 2S, 50, 100 
and 200pM). The concentration o f glucose used in this experiment was very much lower 
than that shown in Figure 3.4.1; 2SmM as opposed to SOOmM. Fluorescence was 
measured at both excitation 32Snm/emission 37Snm and excitation 370nm/emission 
440nm. The two wavelengths follow the same trend for all three proteins, hence only the 
excitation 32Snm/emission 37Snm results are shown.
Both native HSA (Figure 3.4.2) and delipidated HSA (Figure 3.4.3) show an increase in 
fluorescence when the added copper concentration is above lOjaM (in addition to the 
trace contaminants in the phosphate buffer). At concentrations o f added copper at and
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below 10|j,M little increase in fluorophore production is observed. The increase in 
fluorophore production is dose dependent for 50, 100 and 200jj.M of added Cu".
Figure 3.4.4 shows that very little fluorophore is produced in transferrin even when the 
concentration o f copper ions is as high as 100p.M. However, when 200jj.M copper is 
used, there is a slight increase in fluorescence.
3.4.2 Effect o f CuH on sugar induced protein fragmentation
The effect o f added Cu" ions on the fragmentation o f HSA can be seen in Figure 3.4.5. 
There is very little fragmentation of HSA under this set o f experimental conditions unless 
additional Cu" is present. Lanes C and D show native HSA incubated with glucose, with 
and without Cu" respectively. Lanes G and H show delipidated HSA incubated under the 
same conditions. There is a very large increase in the amount of protein fragmentation in 
the two samples which have Cu" included (lanes D and H). As in Figure 3.2.3, the 
fragmentation is seen mostly as a smear with diffuse bands appearing at approximately 15 
and 26 - 33kD. The samples incubated with Cu" in the absence o f glucose show no 
fragmentation (lanes E and J). In Figure 3.3.4 the same proteins showed significant 
fragmentation in the absence of added Cu", but the concentration o f glucose in that 
incubation is 10-fold higher than that used in this experiment.
Figure 3.4.6 shows human transferrin which has been incubated with glucose (lane C) and 
both glucose and Cu" (lane D). Several discrete fragments form in the incubation which 
includes added Cu" and glucose, but no fragmentation is seen in the sample incubated 
with glucose alone. The masses of these discrete fragments have been calculated from a 
log plot to be around 62,41, 32 and 16kD.
A dose-dependent increase in fragmentation of native HSA (Figure 3.4.7) and transferrin 
(Figure 3.4.8) is seen when increasing concentrations of Cu" are added to the
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incubations. For native HSA the intensity of the smearing increases with Cu" 
concentration, although no fragmentation can be observed where the Cu" concentrations 
are below 50|.iM. The transferrin fragments o f 32 and 41kD increase in intensity as Cu" 
concentration increases. This effect is seen throughout the range o f Cu" concentrations 
used. However, even at the maximum concentration of Cu" used (200pM) the 
fragmentation o f both proteins is not as advanced as in Figures 3.4.5 and 3.4.6.
3.4.3 Effect ofF e "^  on the production o f fluorescent AGEs
The effect that free Fe"^ ions have on the development of fluorescent AGEs was 
investigated by incubating both native and delipidated HSA and transferrin in O.IM 
sodium phosphate buffer (pH7.4). Proteins were incubated at 1 mg/ml with 25mM 
glucose and increasing concentrations o f FeCl^. These incubations were at 37°C over a 
period o f 8 days.
Native HSA shows a slight increase in fluorophore production when iron chloride is 
added to the incubation medium up to a concentration of lG|aM. Above lOjaM FeCl^ the 
increase in the amount of fluorophore production is very small. The delipidated HSA 
(Figure 3.4.10) shows an increase in fluorescence when 10|aM FeCl^ is added to the
incubation, but the fluorescence does not appear to increase with further increases in the 
concentration of FeCL.
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3.4.4 Effect o f FeH on sugar induced protein fragmentation
In Figures 3.4.12 and 3.4.13, both native and delipidated HSA were incubated with 
increasing concentrations of iron chloride in the presence o f 25mM glucose. Fe"^ does 
not appear to induce protein fragmentation in native HSA (Figure 3.4.12), delipidated 
HSA (Figure 3.4.13) or transferrin (Figure 3.4.6, lane F). Unlike Figure 3.4.7, where 
dose-dependent fragmentation o f native HSA is seen with increasing concentrations of 
Cu" ions, no fragmentation is observed even when the concentration o f Fe“  ^ions is 
200|iM. Native HSA (Figure 3.4.12) showed slight production o f high molecular mass 
substances when high concentrations of FeCl^ were included in the incubation. There 
was no sign o f these high molecular mass substances in incubations o f delipidated HSA 
(Figure 3.4.13). Transferrin (Figure 3.4.6) incubated with glucose and Fe"^ (lane F) did 
not fragment, unlike transferrin incubated with glucose and Cu" (lane D).
3.4.5 Summarv
When a high concentration of glucose was used, the fluorescence o f native and 
delipidated HSA was unaffected by the addition o f 100p.M CuSO^ to the incubation 
media, but recombinant HSA showed an increase in the fluorescence. However, at low 
concentrations o f glucose there was an increase in fluorescence in both native and 
delipidated HSA when only 50|aM CuSO^ was added.
The fragmentation o f native and delipidated HSA can occur in the absence o f added 
copper if glucose concentrations are high (Figure 3.2.3), but when a lower concentration 
o f glucose was used, added copper was needed for fragmentation to occur.
Transferrin produced glycofluorophores in the presence of FeCl^, but when CuSO^ was 
used, there was only a relatively small increase in fluorescence. However, fragmentation 
o f transferrin (which produces four discrete fragments) occurs in the presence o f CuSO^, 
but not FeClg.
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Figure 3.4.1: Fluorescence of native, delipidated and recombinant HSA incubated with 
glucose and copper. Fluorescence at excitation 325nm and emission 375nm of native, 
delipidated and recombinant HSA ail incubated at lOmg/ml in 0.2M sodium phosphate 
buffer, pH 7.4, with glucose (SOOmM) and CuSO^ (SOpM).
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Figure 3.4.2: Fluorescence of native HSA incubated with glucose and increasing 
concentrations of copper. Fluorescence at excitation 325nm and emission 375nm of 
native HSA incubated in O.IM phosphate buffer for 8 days with glucose (25mM) and 
increasing concentrations of CuSO, (0, 10, 50, 100 and 200pM) added to the incubation 
media. Error bars show 1 standard deviation, where n=3.
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Figure 3.4.3: Fluorescence of delipidated HSA incubated with glucose and increasing 
concentrations of copper. Fluorescence at excitation 325nm and emission 375nm of 
delipidated HSA incubated in O.IM phosphate buffer for 8 days with glucose (25mM) 
and increasing concentrations of CuSO^ (0, 10, 50, 100 and 200pM) added to the 
incubation media. Error bars show 1 standard deviation, where n=3.
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Figure 3.4.4: Fluorescence of transferrin incubated with glucose and increasing 
concentrations of copper. Fluorescence at excitation 325nm and emission 375nm of 
transferrin incubated in O.IM phosphate buffer for 8 days with glucose (25mM) and 
increasing concentrations of CuSO^ (0, 10, 25, 50, 100 and 200pM) added to the 
incubation media. Error bars show 1 standard deviation, where n=3.
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Figure 3.4.5: Fragmentation o f native and delipidated HSA incubated with glucose and 
copper. Native HSA (lanes A,C,D and E) and delipidated HSA (lanes F,G,H,I and J) 
were incubated for 8 days in O.IM sodium phosphate buffer with glucose (25mM) in 
lanes C and G, with glucose and CUSO4 (lOOpM) in lanes D and H and with CuSO^ in 
lanes E and J.
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Figure 3.4.6: Fragmentation o f transferrin incubated with glucose, copper, iron and 
DTPA. Transferrin was incubated in O.IM sodium phosphate buffer for 8 days (lane B). 
The incubation media included glucose (25mM) in lane C, glucose and CuSO^ (lOOpM) 
in lane D, glucose and DTPA (ImM) in lane E, glucose and FeCl^ (lOOpM) in lane F and 
CUSO4 and FeClg alone in lanes G and H respectively.
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Figure 3.4.7: Fragmentation o f native HSA incubated with glucose and increasing 
concentrations of copper. Lanes A and B are native HSA incubated alone and with 
25mM glucose respectively. Lanes C to G have native HSA incubated with glucose and 
copper sulphate at concentrations of 10, 25, 50, 100 and 200pM respectively.
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Figure 3.4.8: Fragmentation o f transferrin incubated with glucose and increasing 
concentrations o f copper. Lanes A and B are transferrin incubated alone and wit 
glucose respectively. Lanes C to G have transferrin incubated with glucose and < 
sulphate at concentrations o f 10, 25, 50, 100 and 200pM respectively.
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Figure 3.4.10: Fluorescence of delipidated HSA incubated with glucose and increasing 
concentrations of iron. Fluorescence at excitation 325nm and emission 375nm of 
delipidated HSA incubated in O.IM sodium phosphate buffer (pH7.4) for 8 days with 
25mM glucose and increasing concentrations o f added FeCl^ (0, 10, 25, 50, 100 and 
200|iM). Error bars show 1 standard deviation where n=3.
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Figure 3.4.11: Fluorescence o f transferrin incubated with glucose and increasing 
concentrations o f iron. Fluorescence at excitation 325nm and emission 375nm of 
transferrin incubated in O.IM sodium phosphate buffer (pH7.4) for 8 days with 25mM 
glucose and increasing concentrations o f added FeCl^ (0, 100, 200, 500, 750 and 
1000p.M). Error bars show 1 standard deviation where n=3.
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Figure 3.4.11; Fluorescence of transferrin incubated with glucose and increasing 
concentrations o f iron. Fluorescence at excitation 325nm and emission 375nm of 
transferrin incubated in O.IM sodium phosphate buffer (pH7.4) for 8 days with 25mM 
glucose and increasing concentrations o f added FeCl^ (0, 100, 200, 500, 750 and 
1000|iM). Error bars show 1 standard deviation where n=3.
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Figure 3.4.12: Fragmentation of native HSA incubated with glucose and increasing 
concentrations o f iron. Lanes A and B are native HSA incubated alone and with 25mM 
glucose respectively. Lanes C to G have native HSA incubated with glucose and iron 
chloride at concentrations of 10, 25, 50, 100 and 200pM respectively.
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Figure 3.4.13: Fragmentation of delipidated HSA incubated with glucose and increasing 
concentrations o f iron. Lanes A and B are delipidated HSA incubated alone and with 
25mM glucose respectively. Lanes C to G have delipidated HSA incubated with glucose 
and iron chloride at concentrations of 10, 25, 50, 100 and 200pM respectively.
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3.5 Effect of choice of buffer on AGE formation
It was thought that the phosphate buffer used in earlier work (Figure 3.4.1 ) was 
catalysing the production of fluorophores because it contained traces of contaminating 
transition metals. An alternative low-metal buffer (HEPES, 0. IM , pH 7.4) was chosen to 
carry out the work shown in Figure 3.5.1. Again the three forms of HSA (native, 
delipidated and recombinant) were incubated at lOmg/ml with 500mM glucose and 
50pM CUSO4 , at 37*C for periods of up to 11 days.
3.5.1 Effect of buffer on fluorophore formation
A large increase in glucose induced fluorophore production is seen in all three forms of 
HSA when Cu" ions are added to the HEPES buffered incubation (Figures 3.5.1, 3.5.2 
and 3.5.3). This contrasts with the phosphate buffered incubation (Figures 3.2.2 and 
3.4.1) where only the recombinant HSA produces an increase in fluorescence when Cu° 
is added. In the HEPES buffered system the amount of fluorescence produced with 
glucose alone is approximately 30% of that when Cu'^  is also included in each of the 
incubations. This increase of fluorescence on the addition of Cu" is well in excess of the 
increase in fluorescence seen in recombinant HSA when is added to the phosphate 
buffered system (Figures 3.2.2 and 3.4.1).
The three forms of HSA show similar patterns of fluorescence development in HEPES 
buffer (Figures 3.5.1,3.5.2 and 3.5.3), with each of them showing a lag-phase in the 
development of glycofluorophores over the first 3 to 4 days. The delipidated HSA 
appears to form similar levels of fluorescence in incubations with either HEPES or 
sodium phosphate buffers, whilst the two forms of HSA which have bound lipid have a 
much reduced amount of fluorescence formed when HEPES buffer is used. In Figure 
3.5.4 it can be seen that the amount of fluorescence produced by both the native and
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recombinant HSÂs is similar to that produced by delipidated HSA. Unlike in phosphate 
buffer, in HEPES buffer there is no enhancement of glycofluorophore production by lipid 
bound to HSA. It is not possible to compare the fluorescence values from the two 
experiments directly or precisely as this work was carried out using the Aminco Bowman 
Spectrofluorimeter which was not able to hold its value for standards from day to day 
(See Section 2.3.2).
3.5.2 Effect o f buffer on protein fragmentation
Fragmentation gels of transferrin incubated with glucose in HEPES buffer and in sodium 
phosphate buffer (both at O.IM, pH 7.4) are shown in Figure 3.5.5. Transferrin was 
incubated at 1 mg/ml in each buffer with glucose at 50mM and with copper sulphate 
added as a source of Cu" ions to the phosphate buffer (lOOpM) and to the HEPES buffer 
at concentrations of lOOpM, 1 lOpM and 150pM. The additional CuSO  ^was present in 
the HEPES to compensate for the traces of contaminating transition metals in the 
phosphate buffer (approximately 6 pM). Figure 3.5.5 shows that even with enhanced 
concentrations of Cu^  ^ions beyond the concentration found in phosphate buffer, there is 
little fragmentation of transferrin in HEPES buffer (lanes D, E and F) comp^ed to the 
amount o f fragmentation that occurs in sodium phosphate buffer (lanes C and J). The 
fragmentation of transferrin in the phosphate buffered incubation system gives a pattern 
of fragments similar to that seen in Figure 3.4.6 (lane D). However, transferrin incubated 
in HEPES buffer produces fewer fragments, with only the fragments of 31 and 42kD 
appearing. This shows that a small amount of protein fragmentation does occur in 
HEPES buffered incubations, with the production of both the 16 and 62kD fragments 
being more fully inhibited.
Figure 3.5.6 shows the fragmentation of native HSA in HEPES buffer. Lane B has a 
sample of native HSA incubated in the absence of both glucose and Cu" ions. Lanes C to 
J have samples of native HSA incubated with both glucose and added Cu" ions at various
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concentrations. Lane E has a sample of native HSA incubated with 25mM glucose and 
lOOpM Cu° which are identical conditions to those in lane D of Figure 3.4.5 except that 
the buffer used in Figure 3.4.5 is sodium phosphate. Only a veiy small amount of 
fragmentation occurs in the HEPES buffer and it does not take the form o f a large smear, 
but 3 to 4 discrete bands with masses between 20 and 26kD. Although some 
fragmentation of HSA occurs in HEPES buffer, like transferrin, the fragmentation of 
native HSA can be partially inhibited by the use of HEPES buffer in the place of 
phosphate buffer.
3.5.3 Summarv
These experiments have shown that the use of HEPES buffer in the place of sodium 
phosphate buffer affects both protein fragmentation and the formation of 
glycofluorophores. As there is no difference in the amount of fluorophore production on 
delipidated HSA between the two buffer systems used when Cu" is added, the reduction 
in the amount of fluorophore produced on native HSA in HEPES is in the component 
that is related to the lipid bound to HSA. Fragmentation of both transferrin and native 
HSA is partially inhibited by the use of HEPES buffer, and the pattern of fragments 
produced in HEPES is different from that in phosphate for each protein. Furthermore, 
Figure 3.5.5 shows that the enhanced fragmentation of transferrin in phosphate buffer is 
not due to the trace amounts of transition metal catalysts found in that buffer as even with 
added amounts of Cu", well in excess of those found in phosphate buffer, little 
fragmentation is observed in the HEPES buffered incubations.
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Figure 3.5.1: Fluorescence of native HSA incubated in HEPES.
Fluorescence at excitation 325nm and emission 375nm of native HSA incubated in 0. IM  
HEPES buffer, pH7.4, at lOmg/ml with glucose (SOOmM) and CuSO  ^(SOpM) at 37'*C 
over a period of up to I I  days.
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Figure 3.5.2: Fluorescence of delipidated HSA incubated in HEPES.
Fluorescence at excitation 325nm and emission 375nm of delipidated HSA incubated in 
0. IM  HEPES buffer, pH7.4, at lOmg/ml with glucose (SOOmM) and CuSO  ^(SOpM) at
37°C over a period of up to 11 days.
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Figure 3.5.3: Fluorescence of recombinant HSA incubated in HEPES.
Fluorescence at excitation 325nm and emission 375nm of recombinant HSA incubated in 
O .IM  HEPES buffer, pH7.4, at lOmg/ml with glucose (500mM) and CuSO  ^(50pM) at
37®C over a period of up to 11 days.
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Figure 3.5.4: Fluorescence of native, delipidated and recombinant HSA incubated in 
HEPES. Comparative fluorescence of native, delipidated and recombinant HSA 
(lOmg/ml) incubated in O.IM  HEPES buffer (pH7.4) with ^ucose (500mM) and CuSO^
(50|iM ).
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Figure 3.5.5; Fragmentation of transferrin incubated in HEPES or phosphate buffers. 
10% gel of transferrin incubated in O.IM buffer (either HEPES or sodium phosphate) 
with glucose (50mM) and CuSO^ for 8 days. Lane C contains protein incubated in 
phosphate with lOOpM Cu", Lanes D, E and F are incubations in HEPES with 100, 110 
and 150 |iM Cu" respectively. Lanes G and H contain transferrin incubated with glucose 
alone in phosphate and HEPES respectively and Lane I contains transferrin incubated 
without glucose in phosphate buffer.
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Figure 3.5.6: Fragmentation of native HSA incubated in HEPES.
Native HSA (Img/ml) was incubated in 0. IM  HEPES buffer. Lane B has HSA in buffer 
alone; Lanes C, D and E have HSA with glucose (25mM) and 25, 50 and lOOpiM CuSO^ 
respectively. Lanes F, G and H have HSA with glucose (lOmM) and CuSO^ as above. 
Lanes I and J have HSA with glucose (20mM) and 50 and lOOpM CuSO^ respectively.
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3.6 Effect of glucose preincubation
In order to see whether AGE production was affected by glucose undergoing a metal 
catalysed oxidation reaction prior to contact with the proteins, glucose was incubated in 
phosphate buffer with and without added Cu° (lOpM) before incubating it with HSA. In 
Figure 3.6.2, delipidated HSA incubated with fresh glucose shows a lag-phase of about 2 
days before fluorophore production begins, whether the incubation media has added Cu  ^
ions or not. The samples of delipidated HSA with preincubated glucose do not show this 
same lag-phase in fluorophore production and clearly have faster initial rates. A slight 
enhancement o f the initial rate of fluorophore production in recombinant HSA (Figure 
3.6.3) is seen when the glucose has been preincubated. The most noticeable feature in 
this figure is the difference in the rate of fluorophore formation between the samples 
incubated with and without Cu" in the final incubation regardless o f whether the glucose 
was preincubated.
Fluorescence formation in native HSA (Figure 3.6.1), which unlike that of recombinant 
HSA is not enhanced by the presence of additional Cu" in the incubation (Figures 3,2.2 
and 3.4.1) does not have the lag-phase when the protein is incubated in phosphate buffer 
with fresh glucose. No enhancement in the initial rate of fluorophore production is seen 
in native HSA when the glucose used in the incubation has been preincubated in 
phosphate buffer either with or without additional Cu" ions.
It can be seen that the preincubation of glucose influences the production of fluorescent 
AGEs in both delipidated and recombinant HSA to at least a small extent. From this data 
it is not possible to tell if  the oxidation of glucose prior to reaction with protein is only a 
minor side reaction contributing only to the initial enhancement of glycofluorophore 
production which covers the period of the lag-phase or if  the lag-phase seen with fresh 
glucose is the result of the time taken for the products of glucose autoxidation to build 
up.
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Figure 3.6.1: Fluorescence of native HSA incubated with copper and preincubated 
glucose. Native HSA incubated at lOmg/ml in 0. IM  sodium phosphate buffer (pH7.4) at 
37®C for up to 11 days. Glucose was included in all samples at SOOmM. Two of the 
samples were incubated with fresh glucose, one with added CuSO  ^(Ip M ), ( a) and one
without (# ). In addition to this, two o f the samples of glucose had been pre-incubated in 
phosphate buffer for 3 days, one with CuSO  ^(1 OpM) in the pre-incubation medium ( a ),
and the other having copper added to it when the incubation with protein began (* ) .
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Figure 3.6.2: Fluorescence of deUpidated HSA incubated with copper and preincubated 
glucose. Delipidated HSA incubated at lOmg/ml in 0. IM  sodium phosphate buffer 
(pH7.4) at 37®C for up to 11 days. Glucose was included in all samples at SOOmM. Two 
of the samples were incubated with fresh glucose, one with added CuSO  ^(1 pM), ( ■ )
and one without ( #). In addition to this, two o f the samples of glucose had been pre- 
incubated in phosphate buffer for 3 days, one with CuSO  ^(lOpM) in the pre-incubation
medium (a ), and the other having copper added to it when the incubation with protein 
began ( • ) .
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Figure 3.6.3: Fluorescence of recombinant HSA incubated with copper and preincubated 
glucose. Recombinant HSA incubated at lOmg/ml in 0. IM  sodium phosphate buffer 
(pH7.4) at 37°C for up to 11 days. Glucose was included in all samples at SOOmM. Two 
of the samples were incubated with fresh glucose, one with added CuSO  ^(Ip M ), ( ■) and
one without (« ). In addition to this, two o f the samples of glucose had been pre- 
incubated in phosphate buffer for 3 days, one with CuSO  ^ (lOpM) in the pre­
incubation medium (a ), and the other having copper added to it when the incubation with 
protein began ( ♦).
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3.7 Beha^nour of different reducing sugars
Sugar-induced changes to protein structure are known to occur at different rates for 
different sugars. Furthermore, a different picture is seen if  the reaction is monitored at an 
early stage, i.e. the formation of Amadori product, or at a later stage, e.g. the formation 
of glycofluorophores. I  therefore compared the amounts of Amadori product and 
glycofluorophores produced in a set time when HSA was incubated with glucose or 
fructose. Native HSA was incubated for 5 days in 0.05M sodium phosphate buffer 
(pH7.4 / 3mM sodium azide), at 37°C with lOmM and SOOmM glucose or lOmM 
fructose.
3.7.1 Production of Amadori product bv both glucose and fiuctose
The samples were extensively dialysed to remove unbound sugar and the protein and 
periodate assays were carried out to establish the number of moles of Amadori product 
per mole of protein. There was little difference in the amount of Amadori product 
detected by the periodate assay for the protein incubated with either lOmM glucose or 
lOmM fhictose. The protein incubated with SOOmM glucose showed a large increase in 
the number of moles of Amadori product per mole of protein (Figure 3 .7.1)
3.7.2 Production of glycofluorophores bv glucose and fhictose
Fluorescence was measured at both excitation 32Snm/emission 37Snm and excitation 
370nm/emission 440nm. Figures 3.7.2 and 3.7.3 show fluorophore production at both 
sets of wavelengths respectively. Little or no fluorophore production was seen in the 
sample incubated in lOmM glucose. The sample incubated with SOOmM glucose showed 
fluorophore production which was similar at both the wavelengths. The largest incre^e
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in fluorophore production was seen in the samples which were incubated with lOmM 
fructose. Unlike the incubations in glucose, in which the fluorescence at both 
wavelengths was very similar, the fluorescence produced at excitation 370nm and 
emission 440nm was markedly greater than that produced at the other wavelength.
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Figure 3.7.1: Formation of Amadori product on native HSA incubated with either 
fructose or glucose. Amount of Amadori product formed per mole of protein when 
native HSA (lOmg/ml) was incubated with lOmM and SOOmM glucose and lOmM 
fructose in O.OSM sodium phosphate buffer (pH 7.4) at 37°C for S days. (A) represents 
incubation without sugars, (B) incubation with lOmM glucose, (C) incubation with 
SOOmM glucose and (D) incubation lOmM fructose. Error bars show 1 standard 
deviation, where n=3.
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Figure 3.7.2: Fluorescence of native HSA incubated with glucose or fructose. 
Fluorescence at excitation 325nm and emission 375nm of native HSA (lOmg/ml) 
incubated with lOmM and SOOmM glucose and lOmM fructose in O.OSM sodium 
phosphate buffer (pH 7.4) at 37®C for S days. (A ) represents incubation without sugars, 
(B) incubation with lOmM glucose, (C) incubation with SOOmM glucose and (D) 
incubation lOmM fructose. Error bars show 1 standard deviation, where n=3.
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Figure 3.7.3; Fluorescence at excitation 370nm and emission 440nm of native HSA 
incubated with glucose and fiuctose. Fluorescence at excitation 370nm and emission 
440nm o f native HSA (lOmg/ml) incubated with lOmM and SOOmM glucose and lOmM 
fiuctose in O.OSM sodium phosphate buffer (pH 7.4) at 37°C for S days. (A ) represents 
incubation without sugars, (B) incubation with lOmM glucose, (C) incubation with 
SOOmM glucose and (D) incubation lOmM fiuctose. Error bars show 1 standard _ 
deviation, where n=3.
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3.8 Inhibition of AGE formation
Four compounds were looked at with respect to their abilities to inhibit the reactions that 
produce fluorophores. Transferrin and native and delipidated HSA were incubated at 2 
mg/ml in O.IM  sodium phosphate buffer, pH 7.4, with glucose (lOOmM) for 8 days at 
37°C. Also included in the incubations were the compounds aminoguanidine, propyl 
gallate, trolox (a water soluble v it^ n  £  derivative) and acetyl salicyclic acid, each at 
concentrations of 2SpM, 250pM, 2.5mM, lOmM and 25mM. Fluorescence was 
measured at excitation 325nm and emission 375nm.
3.8.1 Aminoguanidine
Aminoguanidine is thought to block glycofluorophore formation by scavenging 
dicarbonyl compounds that are formed either fi-om the breakdown of Amadori product or 
directly from fructose. It is thought that these dicarbonyl compounds play a major role in 
the formation of glycofluorophores. Figure 3.8.1 shows the fluorescence of native and 
delipidated HSA and transferrin where aminoguanidine is being used as an inhibitor. 
Aminoguanidine incubated with all three proteins in the absence of glucose gives a very 
similar fluorescence value to that of the proteins incubated in buffer alone. The inhibition 
of protein fluorescence in the presence of glucose is dose dependent with respect to the 
concentration of aminoguanidine in the incubation mixture. Fluorescence formation at 
25pM aminoguanidine is approximately 50% of the uninhibited fluorescence formation 
for both forms of HSA, but transferrin appears to need much higher concentrations of 
aminoguanidine to inhibit fluorescence formation to the same extent.
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3.8.2 Propyl Gallate
Propyl gallate is a free radical scavenger which also has transition metal binding 
properties. Figure 3.8.2 shows the fluorescence production for native and delipidated 
HSA and transferrin where the compound propyl gallate is being tested as an inhibitor. 
The fluorescence of propyl gallate incubated alone with protein is significantly higher than 
that of protein incubated alone, although it is still much lower than the values obtained for 
each of the three proteins incubated with glucose. Propyl gallate inhibits fluorescence 
formation in all three proteins even at 25pM. Inhibition of fluorescence at this 
concentration of propyl gallate is much greater in native HSA than in transferrin, with 
inhibition in delipidated HSA falling somewhere between the other two proteins. High 
concentrations of propyl gallate in the presence of glucose produce large amounts of 
fluorescence and in the case of HSA both proteins produce greater amounts of 
fluorescence with 25mM propyl gallate when glucose is present than when glucose is 
absent from the incubation. It seems that inhibition of glucose derived fluorescence is 
either being masked by fluorescence derived from an interaction between propyl gallate 
and glucose or that inhibition is no longer occuring at higher concentrations of propyl 
gallate.
3.8.3 Trolox
Vitamin E isa  well known scavenger of free radicals and trolox is a water soluble 
derivative of this compound. Figure 3.8.3 shows the effect of trolox on fluorescence 
production in native and delipidated HSA and transferrin incubated with glucose. The 
control sample containing trolox incubated alone with each protein has a very high 
fluorescence value, which in delipidated HSA is nearly as high as the fluorescence 
produced in the control containing the protein with glucose. In transferrin the 
fluorescence produced by incubation of trolox alone with transferrin is very much greater 
than that produced by transferrin incubated with glucose alone. Inhibition of glucose 
induced fluorescence is seen in both native and delipidated HSA although at high
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concentrations of trolox this effect is masked by the amount of fluorescence produced by 
the increasing concentrations of trolox. No inhibition of glucose derived fluorescence is 
seen in transferrin incubated even with very low concentrations of trolox. The 
fluorescence of these samples rises in a dose-dependent manner vrith the concentration of 
trolox.
3.8.4 Acetyl Salicvclic Acid
The fluorescence of all three proteins incubated with acetyl salicyclic acid is much greater 
than the fluorescence obtained from samples where the proteins were incubated with 
glucose alone. This difference in fluorescence values is so great that the samples where 
proteins were incubated with glucose alone barely show on the same scale of graph as 
those incubated with acetyl salicyclic acid either in the presence or absence of glucose. 
Little information on whether there is any inhibition of glycofluorophore production can 
be obtained from these results, as at present there is no way of separating the the 
fluorscence derived from the acetyl salicyclic acid from the glucose derived fluorescence.
3.8.5 Summary
Aminoguanidine is a good inhibitor of fluorophore production as monitored at excitation 
325nm and emission 375nm. Both propyl gallate and trolox act as inhibitors of this 
reaction (except for fluorophore production on transferrin in the presence of trolox). In 
all three proteins high concentrations of both propyl gallate and trolox give misleading 
results as some new fluorophore is produced which masks the formation (or inhibition) of 
glucose derived fluorophores on the three proteins. With both these compounds, 
production of a yellow chromophore is dependent on the concentration of the inhibitor 
and not on the presence of glucose in the incubation media. Acetyl salicyclic acid is a 
very effective promoter of fluorescence at the wavelengths used here and due to this it is 
impossible to see if  it inhibits the formation of glucose induced fluorophores.
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Figure 3.8.1: Aminoguanidine as an inhibitor
Fluorescence of native and delipidated HSA and transferrin incubated in phosphate buffer 
only (A), with lOOmM glucose (B), with 25mM aminoguanidine (C) and with lOOmM 
glucose and aminoguanidine at 25|iM  (D ), 250pM (E), 2.5mM (F), lOmM (G) and 
25mM (H).
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Figure 3.8.2: Propyl gallate as an inhibitor
Fluorescence of native and delipidated HSA and transferrin incubated in phosphate buffer 
only (A ), with lOOmM glucose (B), with 25mM propyl gallate (C) and with lOOmM 
glucose and propyl gallate at 25|iM  (D ), 250pM (E), 2.5mM (F), lOmM (G) and 25mM 
(H ).
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Figure 3.8.3; Trolox as an inhibitor
Fluorescence of native and delipidated HSA and transferrin incubated in phosphate buffer 
only (A), with lOOmM glucose (B), with 25mM trolox (C) and with lOOmM glucose and 
trolox at 25^iM (D), 250jiM (E), 2.5mM (F), lOmM (G) and 25mM (H).
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3.9 Effect of relative concentrations of protein and glucose
It is known that the formation of Amadori product is effectively first order with respect to 
glucose concentration providing that other conditions are kept constant (see Figure
3.2.1). Throughout the literature (and also this project) different concentrations of 
proteins and sugars are used for in vitro investigations. Therefore the following 
experiment was carried out in an attempt to determine whether fluorescent AGEs are 
dependent on the relative concentrations of glucose and protein in the same way as the 
formation of the Amadori product.
Transferrin was incubated at 1, 10, 20 and 40 mg/ml in 0. IM  sodium phosphate buffer, 
pH 7.4, for 8 days and the fluorescence of these samples was measured at excitation 
325nm and emission 375nm. Samples included glucose at concentrations of 25 or 
lOOmM, and CuSO  ^at lOOpM.
Figure 3.9.1 shows the increase in fluorescence (compared to the fluorescence of 
transferrin incubated without glucose) of transferrin incubated at 1,10,20 and 40 mg/ml 
under the four different sets of conditions. All samples of transferrin were diluted to 
0.5mg/ml before fluorescence was measured. For every set of conditions used the 
fluorescence produced by the sample of transferrin incubated at 1 mg/ml was much greater 
than for the others. There was a steady reduction of fluorophore formation in parallel 
with the increasing concentration of protein in the original incubation. The relative molar 
ratio of glucose to protein was 40 times greater for the sample incubated at 1 mg/ml than 
for the sample incubated at a protein concentration of 40mg/ml, but the observed rise in 
fluorescence was approximately only 7 fold.
Tables 3.9.1 and 3.9.2 show the molar ratio of both glucose and acyclic glucose to 
transferrin for all samples and the increase in fluorescence that is observed for each. The 
same relative concentration of reactants exists when the protein concentration is 40mg/ml
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and the glucose concentration is lOOmM as when the protein is incubated at 10 mg/ml 
with 25mM glucose. However, the amount of fluorescence produced by the sample of 
protein incubated at 40 mg/ml is ten times higher than that produced by the incubation at 
lOmg/ml. These results show that what appears to be an excess of glucose in in vitro 
reactions, may in fact not be.
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Table 3.9.1 : Molar ratios of glucoseitransferrin and increase in fluorescence when
transferrin is incubated with 25mM glucose
Transferrin
Concentration
GlucoseiTfh 
(molar ratio)
Acyclic GlucoseiTfh 
(molar ratio)
Fluorescence 
Increase 
(Arbitrary units)
Img/ml 1984.1 0.0397 34.9
10 mg/ml 198.1 3.967 X 10-3 2.2
20 mg/ml 99.2 1.984x10-3 5.7
40 mg/ml 49.6 9.921 X  10-4 3.3
Table 3.9.2: Molar ratios of glucose:transferrin and increase in fluorescence when
transferrin is incubated with lOOmM glucose
Transferrin
Concentration
GlucoseiTfh 
(molar ratio)
Acyclic GlucoseiTfh 
(molar ratio)
Fluorescence 
Increase 
(Arbitrary units)
Img/ml 7936 0.159 169.1
10 mg/ml 793.6 0.0159 42.9
20 mg/ml 396,8 7.936 X  10-3 31.2
40 mg/ml 198.4 3.97x10-3 20.7
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Figure 3.9.1: Fluorescence of transferrin incubated at varying concentrations in both 
25mM and lOOmM glucose. Fluorescence at excitation 325nm and emission 375nm of 
transferrin incubated at 1, 10,20 and 40mg/mi with: (a) 25mM glucose, (b) lOOmM 
glucose, (c) 2SmM glucose and lOOpM CuSO  ^and (d) lOOmM glucose and lOOpM 
CUSO4 .
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3.10 Choice of fluorescence wavelengths
Throughout the literature the development of glucose induced fluorophores has been 
followed at different excitation and emission wavelengths. The three principal sets of 
fluorescence wavelengths used by other researchers are excitation 325nm/emission 
375nm, excitation 370nm/enussion 440nm and excitation 360/emission 454nm. Clearly it 
was impractical to measure the fluorescence in every experiment at all three sets of 
wavelengths. Therefore, emission scans of both glycated and non-glycated native HSA 
were carried out at excitation wavelengths o f325,370 and 360nm in order to decide 
which set of wavelengths to use. In all three cases the amount of fluorescence produced 
by the glycated HSA far exceeds the amount produced by the non-glycated HSA (Figure
3.10.1). None of the emission scans show their maxima at the wavelengths listed above. 
The emission marima for excitation at 325nm was 405nm, for excitation at 370nm it was 
432nm and for excitation at 360 it was 425nm. The increase in fluorescence formation 
seen on incubation of native HSA with glucose in relation to the fluorescence of the 
starting material is greatest when the excitation wavelength is 325nm. Therefore the use 
of 325nm as the exciting wavelength seems to be a good choice for following glucose 
induced changes in protein fluorescence. Emissions had to be read at 375nm throughout 
all the experiments so that results obtained could be compared directly with those in the 
literature.
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Figure 3.10,1: Emission scans of glycated and non-glycated native HSA at excitation 
wavelengths of 325nin, 370nm and 360nm.
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DISCUSSION
4.1 Glucose Dependency of AGE Production
Many covalent changes take place in proteins on aging [Stadtman, 1988], so it is essential 
to establish by experiments like those in Section 3.1, that the formation of fiuorophores and 
the fragmentation of proteins are due to reactions of glucose, rather than some other change 
occuring on the protein during incubations. Throughout the work in this project it has been 
shown that the formation of fluorescence and the fragmentation of proteins does not occur 
unless a reducing sugar is present in the incubation medium. Figures 3.1.1, 3.1.2 and 3.1.3 
show that fiuorophores are not formed in any of the types of HSA used, unless glucose is 
included in the incubation. Figure 3.1.4 shows that neither native nor delipidated HSA 
fragment in the absence of glucose. The dependency on glucose of protein fragmentation is 
not exclusive to HSA, and has been seen in transferrin (Figure 3.4.6) and DSA (Figure
3.2.4).
Le Guen et al (1992) noted considerable increases in the fluorescence of both delipidated 
and native BSA in the absence of glucose, although when glucose was included in the 
incubation medium, the increase in fluorescence for each form of BSA was much greater. 
One possible explanation for the differences between her results and mine could be that Le 
Guen et al measured fluorescence at excitation 360nm and emission 4S4nm whilst I  used the 
'pentosidine wavelength' o f excitation 325nm and emission 375nm, which has been shown to 
be more specific for glucose induced fiuorophores than cither the wavelengths used by Le 
Guen et al or the commonly used wavelengths of excitation 370nm and emission 440nm 
(Section 3.10).
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Using BSA as their model protein. Hunt et al (1988b) also showed that the fragmentation of 
protein was glucose dependent However, in the absence o f glucose, BSA and other 
proteins have been shown to fragment when exposed to a source of free radicals, such as 
hydrogen peroxide and lipid hydroperoxides [Hunt et al, 1988b] or to hydroxyl and 
superoxide radicals derived from a ^ ^Co source [Davies et al, 1987a]. I  observed a very 
small amount of fragmentation in glucose free incubations of transferrin that had high 
concentrations of copper, but it is possible that Amadori product that had been formed on 
the protein prior to isolation was involved in this reaction.
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4,2 Effect of protein-bound lipid on the production 
of Amadori product and AGÊs in HSA
4.2.1 Effect o f bound lipid on Amadori product formation
The production of Amadori product on HSA is not affected by lipid bound to the protein 
(Figure 3.2.1). Similar experiments by Mereish et al (1982) showed the amount o f 
radioactive glucose bound to HSA to be significantly higher for delipidated HSA than for 
native HSA. This difference in results can be explained by the experimental conditions used 
by Mereish (Section 1.12.1).
4.2.2 Effect of bound fatty acid on fluorescent AGE formation
Glucose-induced fluorescence in native HSA is significantly higher than in delipidated HSA, 
despite the similarity in the amount of Amadori product formed by each of these proteins. 
This strongly suggests that bound lipid enhances the formation of glycofluorophores. When 
the experiment was repeated using HEPES buffer instead of phosphate, native HSA no 
longer had enhanced fluorescence (Section 3.5.6). As HEPES buffer is known to have 
radical scavenging properties [Halliwell and Gutteridge, 1989], these results suggest that 
the lipid-dependent fluorophore formation is a free radical mediated reaction.
The finding that delipidated HSA does not produce fiuorophores to the same extent as 
native HSA agrees with work on BSA [Le Guen et al, 1992]. Le Guen et al also suggested 
that glucose-induced fluorescence on BSA was made up of several components. I  have 
shown that there are at least two components of glycofluorophore production on HSA that 
has bound lipid; a lipid-independent component and a lipid-dependent component. The 
change in conformation that HSA undergoes when fatty acids are bound to it [Shaklai et al, 
1984] was initially thought to be responsible for the enhanced formation of fiuorophores on
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native and recombinant HSA. However, it has been shown that the lipid-dependent 
component of fluorophore formation is a radical mediated reaction, which suggests that 
glycofluorophore production may also be enhanced by products o f lipid peroxidation 
reactions.
When DTPA was included in the reaction mixture to chelate traces of transition metal found 
in phosphate buffer, only the fluorophore formation on delipidated HSA was entirely 
inhibited (Figure 3.3.2). It appears that lipid-dependent fluorophore formation was either 
still catalysed by the chelated metal ions [Miller et al, 1990], or did not require the presence 
of transition metal ions. This adds further weight to the conclusion that glucose-derived 
fluorescence on HSA with bound lipid is made up of more than one component.
Recombinant HSA also forms significantly more glucose-derived fiuorophores than 
delipidated HSA, although it only forms approximately 80% of the fluorescence of native 
HSA (Figure 3.2.2). Recombinant HSA has a much larger percentage of saturated fatty 
acids bound to it than native HSA [Delta Biotechnology Limited (Data Sheet); Saifer and 
Goldman, 1961]. The inability of saturated lipids to undergo peroxidation reactions may be 
responsible for the lower amounts of fluorophore produced by the recombinant HSA 
[Halliwell and Gutteridge, 1989]. An additional explanation for the enhanced production of 
fiuorophores by native HSA is that the protein has become glycated in vivo prior to 
isolation from serum which may enhance the initial rate of fluorophore production. The 
lower levels of copper bound to recombinant HSA could be a further possible reason for the 
depressed fluorophore formation (See Section 4.4.1).
4.2.3 Effect of bound fatty acid on protein fragmentation
Glucose-induced fragmentation of HSA does not appear to be affected by bound fatty acids 
(Figure 3.2.3). This was unexpected as I  found that lipid enhances glycofluorophore 
formation via a radical mediated reaction. It is also known that free radicals [Davies et al.
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1987a] and lipid peroxides [Hunt and Dean, 1989] can cause protein fragmentation, and it 
has been shown that the glucose-induced fragmentation of HSA is a free radical mediated 
reaction (Section 3.5.2). Figure 3.2.3 shows that any free radicals formed by interaction 
with the lipids are not in a position to cleave the protein backbone. These radicals may 
react either with the lipid itself, or at a site on the protein which is not vulnerable to 
fragmentation, possibly resulting in fluorophore formation.
When the fragmentation of both native and delipidated DSA was investigated it was found 
that unlike HSA  ^the two forms of dog albumin did not fragment identically (Figure 3.2.4). 
Contraiy to expectations, it was the delipidated DSA which had enhanced fragmentation 
rather than the native DSÀ. Clearly, bound lipid does not play a catalytic role in 
fragmentation of HSA, and in addition it somehow protects DSA from glucose-induced 
fragmentation. Two possible reasons why delipidated DSA is more vulnerable to glucose- 
induced fragmentation are;
(i) the removal o f fatty acids exposes amino acid residues which can be oxidised to 
produce free radicals that can lead to cleavage of the protein backbone [W olff and 
Dean, 1986] and
(ii) delipidation of albunün is known to cause a conformational change in the protein 
(where the C-terminal becomes less closely packed) [Drôge et al, 1988]; this could 
make parts of the protein backbone more vulnerable to either radical attack or attack 
by proteases.
The possible mechanisms of cleavage of the protein backbone will be discussed further in 
Section 4.10.2.
4.2.4 Aggregation
Only one further contrast between native and delipidated serum albumins showed up in this 
project, This can be seen in Figures 3.4.12 and 3.4.13 where the two proteins have been 
incubated in a phosphate-buffered glycation system with additional Fe™ ions. Where the
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concentrations o f iron are high, the native HSA appears to form some high molecular 
weight products and the delipidated HSA does not. Malondialdehyde (M DA) is a 
secondaiy product of lipid peroxidation which is a very potent protein cross-linker 
[Halliwell and Gutteridge, 1989]. It is possible that where concentrations o f iron are very 
high, the lipids bound to native HSA, which may already have undergone initial reactions of 
lipid peroxidation [Fletcher and Tappel, 1971], react further to form MDA. As only 6% of 
the lipids bound to native albumin have the capacity to readily undergo lipid peroxidation 
reactions [Saifer and Goldman, 1961], the effect observed here is probably a minor reaction 
observed only under extreme reaction conditions such as at very high concentrations of iron 
ions.
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4.3 Effect of trace transition metals on AGE formation
Both fluorophore formation and fragmentation of proteins were shown to require the 
presence of catalytic amounts of transition metals. Phosphate buffer contains traces of 
copper and iron which were thought to be catalysing the formation of AGEs. To 
demonstrate this, DTPA was added to the incubations to try to prevent the copper and iron 
from acting as catalysts o f oxidation reactions.
4.3.1 Fluorescence
Fluorescence inhibition was 100% only for the delipidated HSA. Fluorescence of native 
HSA was inhibited by only 88% and recombinant HSA by only 63%. Since the DTPA 
(Im M ) is well in excess o f the trace contaminants of Cu° (4pM ) and Fe*" (5pM ) it is 
unlikely that there were any unchelated metal ions in solution. Fu et al (1992) also found 
incomplete inhibition of fluorescence development at the same wavelengths, in collagen 
incubated with glucose and DTPA. This "leakage" could be because metal ions chelated to 
DTPA still retain a certain amount of their catalytic ability. Transition metals, and in 
particular iron, have been shown to retain some of their ability to catalyse o;ddation 
reactions whilst bound to DTPA. Neither the chelators DTPA or desferrioxamine are able 
to bind metals in completely inert complexes and there does not appear to be any chelator 
capable of entirely blocking the catalytic abilities of these metals [M iller et al, 1990]. It is 
interesting to note that whilst the formation of fiuorophores on delipidated HSA is entirely 
inhibited by the addition o f DTPA, both the native and recombinant HSAs (which both have 
bound lipid) still form some fluorescence when DTPA is included in the incubation medium. 
One possible explanation for this is that the chelated transition metals are unable to catalyse 
the formation of lipid-independent fluorescence, but that they retain enough catalytic 
activity to catalyse the formation of lipid-dependent fluorescence.
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4.3.2 Fragmentation
Fragmentation was completely inhibited by the addition of DTPA for all of the proteins 
investigated (Figures 3.3.4 and 3.4.6), showing that the process involves a transition-metal- 
catalysed reaction which may be a radical generating reaction such as the Fenton reaction. 
This finding is in agreement with Hunt et al (1988b) where complete inhibition of the sugar- 
induced fragmentation o f BSA in a phosphate-buffered incubation was observed when 
DTPA was added to incubations.
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4.4 Effect of CuH and FeSI on AGE formation
Both Cu  ^and Fe™ ions are present as trace contaminants in sodium phosphate buffer^  so in 
order to see whether the catalytic effect seen was due to one or other of these metals, 
additional quantities of Cu  ^and Fe™ ions were added to the incubations.
4.4.1 Effect of CuS on fluorescent AGE formation
When additional Cu° ions are added to the phosphate-buffered glycation system used in 
Figure 3.2.2, only the recombinant HSA has enhanced fluorophore formation (Figure 3.4.1). 
No enhancement o f fluorophore production in either of the HSAs purified from human 
serum is observed. Recombinant HSA is produced in a very low copper environment so it 
does not have as much bound copper as the other forms of HSA derived fi*om serum [Delta 
data sheet]. In  vivo there is less than 1 mole of copper bound per mole of HSA [Naik et al, 
1975], but it is possible that more copper becomes bound to HSA during its purification 
process. Copper bound to HSA has been shown to retain its capacity to catalyse oxidation 
reactions [Halliwell and Gutteridge, 1989]. It is possible that at high glucose concentrations 
(500mM), both the native and the delipidated HSA have sufficient copper (both fi'om the 
contaminants in the phosphate buffer and the copper that is already bound to the protein) 
for the reaction to proceed at the maximum rate for that particular set of reaction 
conditions.
When additional Cu^  ^is added to the incubations, recombinant HSA produces as much 
fluorophore as the native HSA. This implies that a deficiency in bound copper in 
recombinant HSA is the reason for the lower production of fiuorophores seen in Figure
3.2.2 rather than any difference in the composition of the bound lipid or the protein itself 
(see Section 4.2.2).
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In an attempt to see the effect of Cu" ions more clearly, native and delipidated HSA and 
transferrin were incubated with a much lower concentration o f glucose (25mM rather than 
500mM) with additional CuSO  ^added to the media. The addition of Cu° ions had no effect
on the production of fiuorophores on transferrin except at very high concentrations of Cu°. 
However, both delipidated and native HSA showed dose-dependent increases in 
fluorophore production with additional Cu .^ This indicates that at low concentrations of 
glucose the Cu" catalysed step becomes rate limiting. HSA binds copper very strongly at a 
specific binding site (see Section 1.11.4), and although transferrin has the ability to bind 
copper it does not do so as strongly as HSA. This could be a factor influencing the amount 
of glycofluorophore formed by each. This will be discussed at greater length in Section 
10.1. HEPES buffer has much lower concentrations of transition metal contaminants than 
phosphate buffer. Work done using HEPES buffer (see Section 3.5) shows that even at 
high glucose concentrations, fluorophore formation is boosted by the addition of further 
copper in all three forms of HSA.
4.4.2 Effect of CuB on sugar-induced protein fragmentation
When additional copper was added to the glycation media of HSA, fragmentation occuredh 
The fragments produced can be seen as broad diffuse bands in Figure 3.4.5. The 
approximate masses of these bands are 15 and 26 - 33kD. The 26 - 33kD band shows more 
intense staining at 26 and 33kD than in the intermediate area. Pepsin digests of BSA 
produces firagments of 16, 29 and 34kD [King, 1973]. The 34kD fi*agment found by King 
corresponded to the N-terminal portion of the molecule and the 29kD fragment to the C- 
terminal. Hunt et al (1988a, 1993) obtained three discrete bands with approximate masses 
o f29, 37 and 48 kD, and found no evidence of the non-specific protein firagmentation (such 
as the smearing that is seen in lanes D and H  of Figure 3.4.5). Previous attempts by Ahmed 
(1992) to reproduce the fragmentation pattern of Hunt et al produced no discrete bands. 
Incubations of both BSA and HSA with Cu" and ascorbate produced fragments of 3,18,
22,47 and 50kD [Marx and Chevion, 1985], and it was postulated that these specific
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cleavage sites were linked to low-affînity Cu" binding sites. The masses of the fragments 
obtained in Figure 3 .4.5 correspond most closely to those found by King using pepsin 
digestion. Although the fragmentation observed is glucose-dependent, there may be traces 
of proteases in preparations of HSA [Peters, 1985] which could cause protein 
fragmentation. It is possible that much of the cleavage observed here occurs in the region 
between sub-domains HA and IIB , which would result in the formation of two fragments of 
similar size, such as the fragments o f 26 and 33kD which I  found. For more precise 
identication o f the cleavage sites it would be necessary to sequence parts of each fragment 
and then to compare them with the three dimensional structure of HSA,
Transferrin which has been incubated with glucose and additional Cu" ions in a phosphate- 
buffered system shows very specific fragmentation. Four bands with approximate masses 
16,32, 41 and 62kD are produced (lane D in Figure 3.4.6). Jhoti et al (1988) isolated an 
18kD fragment by subtilisin digestion of ovotransferrin. This retained the capacity to bind 
iron and corresponded to domain I I  of the N-terminal lobe. Tryptic digests o f human 
transferrin produced fragments of masses 43, 36, and 33.5 kD [Evans and Williams, 1978]. 
Both the fragments of 43 and 36 IcD retained their iron binding capacities and it was found 
that the 36 kD fragment was from the N-terminal and the 43kD fragment was from the C- 
terminal. ' The two lobes of transferrin are very similar except the C-terminal has both of the 
carbohydrate moieties, each of mass 2.2kD, attached to it. This may account for the 
difference in mass between the two fragments. MacGillivray et al (1982) obtained a 35kD 
fragment of human transferrin by thermolytic digestion. This fragment retained its iron 
binding capacity. It is possible that the fragments that I  obtained are products of cleavage 
at two specific sites. The first of these sites is likely to be on the peptide joining the two 
lobes of transferrin and the second cleavage site could be between the two sub-domains on 
the N-terminal lobe. The fragments of 41 and 32 kD are probably the result of cleavage of 
the short peptide linking the two lobes of the transferrin molecule, and the fragments of 15 
and 62kD the result of cleavage between the two sub-domains on the N-terminal. It is 
unlikely that the fragment of 15kD could be due to the cleavage between the C-terminal 
sub-domains as the C-terminal domain has both carbohydrate moieties attached to it and
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would therefore give fragments of greater mass. As vrith HSA, it would be necessary to 
carry out amino acid analysis in order to accurately identify the cleavage sites on transferrin.
It can be seen in Figures 3.4.7 and 3.4.8 that there is a dose-dependent increase in glucose- 
induced fragmentation of native HSA and transferrin with added copper. The fragmentation 
in these gels is only slight, but the amount of smearing produced by native HSA and the 
intensity of the 32kD fragment of transferrin both increase with copper concentration.
4.4.3 Effect of FeBk>n fluorescent AGE formation
Iron"' has the capacity to catalyse spin-forbidden oxidation reactions and is the most 
common catalyst for biological free radical mediated processes [Miller et al, 1990; Halliwell 
and Gutteridge, 1989]. It is also one of the principal transition metal contaminants found in 
phosphate buffers along vrith Cu" ions. Unlike copper, iron does not bind strongly to HSA, 
but binds strongly to two sites on human transferrin. Work was therefore carried out with 
Fe™ to elucidate what role is played by the tight binding of transition metals to proteins in 
the formation of glycoxidative products.
The formation of glycofluorophores on native and delipidated HSA increased on adding 
FeClj at concentrations of lOpM (see Figures 3.4.9 and 3.4.10). Beyond this 
concentration, further amounts of FeC^ had little effect on the formation of fiuorophores 
except at 200pM where a small increase was observed in the amount of fluorophore 
produced by delipidated HSA. This effect is very different to the dose-dependent increase 
in fluorophore formation seen in both delipidated and native HSA when Cu" is the species 
of transition metal ion added to the incubation medium.
Transferrin exhibited a clear dose-dependent increase in fluorophore formation with 
increasing concentrations ofFeCl^  (Figure 3.4.11). A higher range of concentrations of 
FeClg was used in incubations of transferrin to see if  fragmentation could be induced by high 
concentrations ofFe'" ions. Even at the lower concentrations ofFeCl^ , which overlapped 
with those used in the incubations of delipidated and native HSA, i.e. lOOpM and 200pM of
126
FeClj, increases in the amount of fluorophore formed were seen. An equivalent increase in 
fluorophore formation was not observed for the samples of HSA at these concentrations of 
FeClj. When it is taken into account that there is no dose-dependent increase in transferrin 
fluorophore formation with Cu", it can be concluded that the specific binding of metals to 
proteins may in some way enhance fluorophore formation.
4.4.4 Effect ofFellLon glucose-induced fragmentation
Neither delipidated or native HSA fragment when Fe"'ions are included in the incubation 
media (Figures 3.4.12 and 3.4.13), unlike the fragmentation of both forms of HSA that is 
promoted by additional Cu" in the glycation incubations (Figure 3.4.5, Lanes D and H). 
More surprising is the lack of fragmentation of transferrin when Fe'" is added to the 
incubation rather than Cu" (Figure 3.4.6, Lanes F and D respectively). This contrasts with 
the increase in fluorescence formation seen when samples of transferrin are incubated with 
FeClj.
4.4.5 Summarv
Iron™ ions are able to catalyse the formation of glycofluorophores on transferrin, but not on 
HSA and Cu" ions catalyse glycofluorophore development in HSA, but not in transferrin. It 
therefore appears that the tight binding of metal ions to proteins can catalyse the formation 
of glycofluorophores. When the fluorescence data is combined with the fragmentation data 
it can be seen that the specific binding of transition metal to transferrin does not play a role 
in the catalysis of protein fragmentation and that of the two transition metals examined, only 
copper is capable of catalysing this reaction. Contrary to the idea put forward by Ahmed 
(1992), the high-affinity binding of transition metals to proteins does not appear to play any 
role in the catalysis of protein fragmentation.
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4.5 Effect of choice of buffer on AGE formation
It was initially thought that phosphate-buffered glycation systems favour glycoxidative 
reactions because they contûn traces of the transition metals copper and iron [Stadtman, 
1990]. This conclusion was confirmed by the inhibition of fi^ agmentation, and the partial 
inhibition o f glycofluorophore production by DTPA (Section 4.3). An alternative buffer, 
HEPES, contains very low amounts of transition metal contaminants compared to 
phosphate buffer, and it is also thought to have radical scavenging properties [Halliwell and 
Gutteridge, 1989].
When the three forms of HSA are incubated in a HEPES-buffered glycation system (Figure
3.5.4) under otherwise identical conditions to those used in the phosphate buffered 
glycation system (Figure 3.2.2), a different pattern o f fluorescence production emerges. In 
the phosphate system both native and recombinant HSA produce significantly more 
fluorescence than delipidated HSA. The fluorescence of delipidated HSA appears to remmn 
essentially unchanged when the buffering system is changed from phosphate to HEPES. 
However, in HEPES both recombinant and native HSA produce much less fluorescence 
than in phosphate. In fact they both produce similar amounts of fluorescence to delipidated 
HSA, showing that it is only the lipid-dependent component o f their fluorescence that is 
inhibited by the HEPES buffer. As HEPES buffer can act as a radical scavenger it seems 
likely that the formation of lipid-^ dependent glycofluorophores is a free radical mediated 
reaction.
Transferrin was selected for comparing fragmentation in different buffers (Figure 3.5.5) 
because of the clear firagmentation pattern it produces in phosphate buffered glycation 
systems where additional Cu" is included (Figure 3.4.6). However, in the HEPES buffered 
glycation system there was much less fragmentation and a different distribution of 
fragments, even though enough copper was added to increase the concentration of metal 
ions above the level found in the phosphate-buffered incubations. The limited fragmentation
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of transferrin seen in Figure 3.5.5 shows that the free radical mediated cleavage of 
transferrin at certain sites can be inhibited by HEPES. Previous work done on 
fragmentation [Davies, 1987; Hunt et al, 1988a], shows that this is a radical mediated 
reaction, which is in agreement with results obtained here. Other buffers with radical 
scavenging properties include Tris, Mes and Mops [Halliwell and Gutteridge, 1989] and 
TAPSO [Fu et al, 1992]. Therefore, choice o f buffer should be an important consideration 
when designing experiments investigating glycoxidative reactions.
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4.6 Role of Glucose Autoxidation
W olff and Dean (1987) have postulated that up to 45% of the products detected by 
common glycation assays is formed not through the Amadori rearrangement of a Schiffs- 
Base (Figure 1.1), but through the reaction of an a-ketoaldehyde, formed by autoxidation 
of glucose (Figure 1.3), with an amino group. Unfortunately W olff was unable to separate 
the possible contributions to AGE formation of glucose autoxidation products and Amadori 
products. However, by preincubating glucose in the absence of protein prior to incubation 
with type 1 comeal collagen. Chase et al (1991) were able to show the effect that glucose 
autoxidation has on the formation of collagen aggregates. A group of experiments 
investigating the effect of preincubating glucose in the presence o f CuSO  ^was carried out 
to see whether the autoxidation of glucose played a significant role in the development of 
fluorescent AGEs on HSA.
The experiments carried out in Section 3.6 looked at the effect of glucose preincubated in 
the presence of CuSO  ^on fluorescence produced by native, delipidated and recombinant 
HSA (Figures 3.6.1,3.6.2 and 3.6.3). Development o f fluorescence in native HSA was 
essentially unchanged by the use of preincubated glucose, but delipidated HSA generated 
more fluorescence during the early stages of the reaction. The lag phase normally seen with 
delipidated HSA was absent whether glucose was preincubated with or without additional 
Cu". This shows that products formed during glucose preincubation play an important role 
in glycofluorophore formation on delipidated HSA, at least during the first two days (under 
the reaction conditions used here). Chase et al (1991) showed that over three days, 
collagen incubated with preincubated glucose had 3-fold higher aggregation than collagen 
incubated with fi-esh glucose. The effect of glucose preincubation on glycofluorophore 
production in delipidated HSA (Figure 3.6.2) was much less than that of collagen. This 
suggests that glucose autoxidation products are more important in the formation of collagen 
aggregates than in the formation of glycofluorophores on delipidated H SA .
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The rate of fluorophore production in delipidated HSA after the lag phase of two days is 
identical, implying that after the initial two days the same mechanism of fluorescence 
formation is occurring in both types of samples. Therefore it is only in the initial part of this 
reaction that the effects o f glucose oxidation products can be seen clearly.
Unfortunately it is not possible to tell fi'om these experiments whether the mechanism of 
fluorophore formation after the lag phase is via an Amadori product intermediate or via the 
glucose autoxidation pathway (Figures 1.1 and 1.3). As it takes several days for the 
Amadori product to form [Baynes et al, 1984], a lag phase such as the one seen here would 
be expected even if  fluorophore formation was occuring solely via the Amadori product. It 
is also possible that the lag phase is due to the time it takes for the glucose to autoxidise 
(either during the preincubation period or during the first two days of incubation with the 
protein). This lends weight to the idea that glucose autoxidation may play a significant role 
in the formation of AGEs. However, going against this idea is the observation that 
Amadori product formation is unaffected by the presence of the metal chelator DTPA [Fu et 
al, 1992]. Once the Amadori product forms it is unlikely that glucose autoxidation is going 
to be a major reaction as Amadori product is autoxidised much more readily than glucose 
[Gilleiy et al, 1988; Azevedo et al, 1988]. This would mean that if  fluorescence was 
forming via an autoxidative reaction, then it would be more likely to be via the autoxidation 
of Amadori product than of glucose. Therefore, despite the initial role the products of 
glucose autoxidation play in the formation of glycofluorophores, it is unlikely that the major 
route for the production of glycofluorophores is via glucose autoxidation.
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4.7 Differences between Glucose and Fructose
Nearly all o f the work in this project looked at reactions involving glucose as the reducing 
sugar. Throughout the literature, differences of reactivity of various reducing sugars have 
been shown [Bunn and Higgins, 1981]. In Section 3.7 it was shown that native HSA gave 
low readings in the periodate assay when incubated with either lOmM glucose or lOmM 
fructose, and high readings when incubated with SOOmM glucose. Native HSA incubated 
with lOmM glucose produced no significant increase in fluorescence, but in SOOmM glucose 
and lOmM fructose (Figures 3.7.2 and 3.7.3), a large increase in fluorescence was seen.
The fluorescence produced by incubation with lOmM fructose is much greater than that 
produced by SOOmM glucose.
It seems that in the case of protein modification by fhictose, there is little relation between 
the formation of Amadori compounds and fluorophore formation. Several factors may 
contribute to this. Firstly, in order to be detected by the periodate assay, sugar-protein 
adducts must have a carbonyl carbon adjacent to a carbon carrying a hydroxyl group, so 
that formaldehyde can be liberated and detected colorimetrically [Furth, 1988]. Therefore 
no cleavage of the carbonyl group will occur in the Heynes product due to the absence of 
hydroxyl groups on the carbon adjacent to the carbonyl group [Furth, 1988] and hence the 
Heynes product is going undetected. McPherson et al (1988) found that approximately 
15% of the " Amadori product" formed from fhictose had in fact the same structure as the 
glucose Amadori product. This suggests that glucose has been formed through the 
énolisation of fructose, and is reacting with the protein.
Alternatively, 3 -deoxyglucosone can be formed directly from fructose without passing 
through an Amadori-type intermediate [Shin et al, 1988]. This therefore opens up a new 
(and rapid) route through which fhictose can produce large amounts of glycofluorophores 
whilst bypassing the formation of Heynes product. Igaki et al (1990) showed that 3- 
deoxyglucosone was a likely intermediate in the formation of fiuorophores, and recently
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Requena et al (1993) suggested from inhibition studies using aminoguanidine that a 
carbonyl intermediate such as 3-deoxyglucosone was involved in the formation of 
glycofluorophores. It has been shown that 3-deoxyglucosone can be formed from the 
Amadori product of glucose. Therefore, in incubations vrith glucose, a build-up o f Amadori 
product would be needed before glycofluorophores could be formed via 3-deoxyglucosone.
It is difficult to say which of these possible explanations for the disparity between 
glycofluorophore production and observed Amadori product formation is the most 
important. Evidence has recently accumulated for the role played by carbonyl intermediates 
in the production of glycofluorophores [Igaki et al, 1990; Kato et ali 1989; Requena et al, 
1993]. Coupled with the ability of 3-deoxyglucosohe to be formed directly from fructose 
[Shin et al, 1988], it is likely that much of the glycofluorophore formation from fhictose 
does not involve the Heynes product as an intermediate.
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4.8 Effect of inhibitors on glycofluorophore formation
To elucidate reaction mechanisms, the potential of four compounds to act as inhibitors of 
glycofluorophore production was examined. Two of the compounds tested were the flree 
radical scavengers propyl gallate and trolox (a water-soluble derivative of vitamin E). Free 
radical scavengers were chosen as potential inhibitors of fluorophore formation due to the 
implications that some of the reactions are free radical mediated processes (see Section 4.5). 
The other two compounds, aminoguanidine and acetyl salicyclic acid, have previously been 
studied as potential inhibitors of glycoxidative reactions [Requena et al, 1993; Swamy and 
Abraham, 1989].
4.8.1 Aminoguanidine
Aminoguanidine is the most effective inhibitor of fluorophore formation of the four 
compounds tested. It is a hydraane compound with three fi'ee amino groups (Figure 1.5). 
Various mechanisms have been postulated for the way in which aminoguanidine acts as an 
inhibitor, but all the more recent evidence has pointed to a mechanism in which 
aminoguanidine reacts with a dicarbonyl intermediate o f the Maillard reaction [Requena et 
al, 1993; Edelstein and Brownlee, 1992], and thus prevents fluorophore formation and 
protein crosslinking.
Aminoguanidine gave a dose-dependent inhibition of fluorophore formation when included 
in incubations of all three proteins used in this study (Figure 3 .8.1). Unlike the other three 
compounds tested, aminoguanidine did not produce any background fluorescence of its 
own when incubated with protein in the absence of glucose, even when the maximum 
concentrations of aminoguanidine was used. Very low concentrations of aminoguanidine 
(25pM) reduced the fluorophore formation in both forms of HSA by over half. However, 
in transferrin the inhibition of fluorophore formation did not begin until the concentration of
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aminoguanidine reached 250pM. If  the mechanism of inhibition involved direct reaction 
between aminoguanidine and glucose, as suggested by Lewis and Harding (1990), then the 
inhibition of transferrin fluorophore formation would resemble that of HSA. As the 
concentration of glucose was identical in all three sets of incubations it can be seen that 
aminoguanidine inhibition of glycofluorophore production does not involve direct 
interaction with glucose.
There is evidence to suggest that the lipid-dependent fiuorophores are formed via a radical 
mediated process (see Section 4.5), but as aminoguanidine is not known to be a radical 
scavenger it is probably inhibiting another step in the formation of lipid-dependent 
fiuorophores. The formation of lipid-dependent glycofluorophores on the native HSA was 
also inhibited, suggesting that there may be interaction of protein or bound lipid with a 
secondary product o f lipid peroxidation, such as malondialdehyde (M DA) [Halliwell and 
Gutteridge, 1989]. Aminoguanidine would then be able to inhibit this reaction in a similar 
way to reactions mediated by 3-deoxyglucosone. MDA, like 3-deoxyglucosone, is a 
dicarbonyl compound which has been shown to produce fiuorophores when incubated with 
proteins [Kikugawa and Beppu, 1987]. Aminoguanidine is a potent scavenger o f 3- 
deoxyglucosone [Oimomi and Igaki, 1989; Edelstein and Brownlee, 1992] so due to the 
structural similarities between 3^deoxyglucosone and MDA (Figure 4.1) it is conceivable 
that the lipid-derived fluorophore formation is blocked by the scavenging of MDA.
4.8.2 Propvl gallate
Propyl gallate is an effective synthetic free radical scavenger with the capacity to bind 
transition metals [Halliwell and Gutteridge, 1989]. When each of the proteins is incubated 
with high concentrations of propyl gallate in the absence of glucose, there is an increase in 
fluorescence production. However, this increase is smaller than the increase in fluorescence 
seen when each of the proteins is incubated with only glucose.
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Figure 4.1 : Structures of 3-deoxyglucosone and MDA
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Inhibition of glycofluorophore production is seen in all three proteins (Figure 3.8.2) when 
the concentration of propyl gallate is at its lowest (25pM). It is the native HSA which has 
the largest amount of inhibition of glycofluorophore production at this low concentration of 
propyl gallate. Only a very small increase in the amount of inhibition is seen in native HSA 
beyond a propyl gallate concentration of 25pM, and beyond 250pM no further inhibition is 
observed. Delipidated HSA and transferrin also show inhibition of fluorophore production 
at 25pM propyl gallate, but this is not nearly as large as for native HSA. Delipidated HSA 
and transferrin show a large decrease in the amount of fluorophore produced when the 
concentration of propyl gallate is increased to 2S0pM. Clearly, the additional lipid-derived 
fluorescence of native HSA is inhibited at very low concentrations of propyl gallate, 
showing that this radical mediated process is readily inhibited by the propyl gallate.
However, as the concentration of propyl gallate rises, the amount of background 
fluorescence also rises to the amount obtained for each of the proteins incubated with 
propyl gallate in the absence of glucose.
Fluorophore formation that is not lipid-dependent has been shown not to be affected by the  ^
radical scavenging properties of HEPES (Section 4.5). The mechanism for inhibition of this 
type o f fluorophore formation by propyl gallate is less clear. It is possible that propyl 
gallate is a more effective radical scavenger than HEPES and is therefore able to scavenge 
the radicals involved in non-lipid-dependent fluorophore formation, but it is also possible 
that the metal chelating properties of propyl gallate are sufficient to prevent the metal- 
catalysed oxidation reactions required for fluorophore formation from occurring.
4.8.3 Trolox
Vitamin E (a-tocopherol) has been tested as a potential inhibitor o f protein glycation 
[Ceriello et al, 1988], and it has also been used as an inhibitor of lipid peroxidation that was 
initiated by a glycated peptide-Fe complex [Sakurai et al, 1991]. Trolox, a water soluble 
derivative of a-tocopherol, was used so that the use of ethanol as a solvent could be 
avoided, and the reaction conditions for all four potential inhibitors would be identical.
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Trolox is a free radical scavenger (Figure 1.5) although unlike propyl gallate it is not known 
to be a metal chelator [Halliwell and Gutteridge, 1989].
Trolox incubated ^ th  each of the proteins in the absence of glucose generates a large 
amount of fluorescence. However, at low concentrations of trolox, inhibition of 
fluorophore formation is visible in both native and delipidated HSA (Figure 3.8.3). As the 
concentration of trolox rises the amount of background fluorescence also rises, thereby 
masking the inhibition seen. However, unlike delipidated HSA, the amount o f fluorescence 
produced by native HSA with 25mM trolox in the presence of glucose falls well short of the 
amount of fluorescence produced in the absence of trolox. This shows that inhibition of the 
lipid component o f glycofluorophore production can be seen despite the large levels of 
background fluorescence produced by the trolox. It is likely that this reaction is being 
inhibited by the radical scavenging abilities of trolox. The inhibition of lipid-independent 
fluorophore production seen in both forms of HSA is unlikely to be due to the radical 
scavenging properties of trolox, as fluorophore formation on delipidated HSA has been 
shown to be unaffected by incubation in HEPES (Section 4.5) and no inhibition by trolox of 
glycofluorophore formation on transferrin is seen. Therefore, the inhibition of this 
component o f the fluorescence could be due to the prevention of Amadori product 
formation on HSA [Ceriello et al, 1988], which in turn would lead to the prevention of the 
formation of the fluorophore precursor 3-deoxyglucosone.
4.8.4 Acetvl Salicvclic Acid
It had been hoped that the blocking of Amadori product formation would lead to a 
reduction in glycofluorophore production and hence give evidence that glycofluorophore 
production on proteins proceeds via an Amadori intermediate. Unfortunately, unless a 
method of separating the fluorescence produced by acetyl salicyclic acid from that produced 
by glucose is developed, the very high amounts of fluorophore produced by acetyl salicyclic 
acid prevent it from being a useful inhibitor in mechanistic studies such as these.
138
4.8.5 Summarv
O f the four compounds investigated here for their potentials as inhibitors o f 
glycofluorophore formation, amino^anidine was the most effective and did not produce 
background fluorescence. Inhibition of glycofluorophore production in all three proteins 
was also seen when propyl gallate was included in the incubations. Trolox inhibited 
fluorophore formation in native and delipidated HSA, but did not inhibit fluorophore 
formation in transferrin. The extremely high background fluorescence produced by acetyl 
salicyclic acid completely masked the fluorescence produced by glucose and proteins. The 
information that was obtained from these experiments is discussed with respect to the 
possible mechanisms of fluorophore formation in Section 4.10.1.
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4.9 Effect of Varying Concentrations of protein and glucose
Many different concentrations of both glucose and proteins have been used throughout the 
literature on glycoxidative reactions. As reaction rates are dependent on both absolute and 
the relative concentrations of reactants, I  decided to investigate the effect of these variables 
on glycofluorophore formation. Transferrin was chosen as the model protein as it has no 
lipid-dependent component of fluorescence, making the production of glycofluorophores a 
simpler reaction to study than in native HSA (See Section 4.2). Also, unlike HSA, which 
gets glycated at several sites, transferrin does not get as heavily glycated [Ney et al, 1985], 
so there will be less variation in the glycated proteins that undergo reactions o f fluorophore 
formation.
I f  it is assumed that Amadori product is a precursor of glycofluorophores, then a possible 
rate determining step in glycofluorophore production is the formation o f Amadori product. 
Unless glucose is in the straight chain form, there is no reactive carbonyl group on it, 
therefore the amount of sugar in the acyclic form may affect the rate at which the Schififs 
base is formed. Hence the production of Amadori product is dependent on the amount of 
glucose present in the acyclic form, providing that the Amadori rearrangement is not the 
rate determining step.
The amount o f fluorophore formed by transferrin (incubated at concentrations o f40,20,10  
and 1 mg/ml) with glucose at a concentration of either 25 or lOOmM is greatest when the 
concentration of transferrin in the incubation is at its lowest (i.e. Img/ml). In Figure 3.9.1 it 
can be seen that the amount of fluorophore produced decreases with increasing 
concentrations of transferrin in the incubations, implying that it was the transferrin that was 
in excess over the glucose. Despite the seemingly large excess of glucose over protein 
(Tables 3.9.1 and 3.9.2), if  the percentage of glucose in the reactive acyclic form is taken to 
be 0.002% [Bunn and Higgins, 1981], it can be seen that the protein does indeed exist in 
large molar excess over the concentration of reactive species of glucose.
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However the production of glycofluorophores is not sinq>ly dependent on the relative 
concentrations o f protein and glucose. The same relative concentration of reactants exists 
when the protein concentration is 40mg/ml and the glucose concentration is lOOmM, as 
when the protein is incubated at lOmg/ml with 25mM glucose. However, the amount of 
fluorescence produced by the sangle of protein incubated at 40mg/ml is ten times higher 
than that produced by the incubation at lOmg/nd. This shows that the rate of fluorophore 
production increases with the absolute concentrations of the reactants, as would be 
expected.
From this work it can be seen that both the relative and absolute concentrations of reactants 
(protein and sugar) can affect the formation of glycofluorophores. Therefore it is not 
possible to make coniparisons between sets of data that have been obtained under non­
identical experimental conditions. This should be e^ecially home in mind when 
extrapolating in vitro models to an in vivo situation.
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4.10 Mechanisms of AGE formation
From the results obtained in this thesis certain conclusions about the mechanisms involved 
in the formation of glycofluorophores and and the sugar-induced fragmentation of proteins 
can be reached.
4.10.1 Mechanisms of glvcofluorophore formation
i) Role of metal-catalysed oxidation
Fluorophore production on HSA has at least two components, a lipid-dependent and a lipid- 
independent component, both of which are formed in a transition metal catalysed reaction. 
Theoretically, all metal-catalysed oxidation involves free radicals [Morrison and Boyd, 
1987]. However, the lipid-independent component of glycofluorophore production, whilst 
metal catalysed, appears to be largely unaffected by the free radical scavenger HEPBS, 
although some inhibition is seen in delipidated HSA incubated with trolox or propyl gallate. 
This may either be due to these compounds being more effective radical scavengers than 
HEPES or to trolox blocking the formation of Amadori product (Section 4.8.3) and propyl 
gallate chelating the transition metals. The formation of fluorophores is a metal catalysed 
reaction, which is enhanced by the high affinity binding of transition metals to proteins. It is 
likely that if the free radicals produced by metal-catalysed oxidation act at their site of 
formation, they may not be completely scavenged by either the HEPES buffer or the trolox.
The lipid-dependent component of glycofluorophore production is completely inhibited by 
HEPES, trolox and propyl gallate showing that this reaction is indeed a free radical 
mediated process. This is in agreement with those who observe inhibition of glycoxidative 
reactions when radical scavengers are included in incubations [Le Guen et al, 1992; Fu et al, 
1992; Hunt and Wolff, 1991].
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The fluorescent modification of HSA by peroxidation of bound lipids was reported by 
Fletcher and Tappel (1971) although this was observed in the absence of glucose. It seems 
likely that the lipids bound to commercially avmlable HSA have already undergone some 
peroxidation reactions, and it is perhaps the reaction of these products with glucose that we 
see in a phosphate-buffered glycation system.
ii) Role of glucose autoxidation products
The glucose autoxidative pathway was put forward by W olff and Dean (1987) as having a 
major role in the formation of AGEs. In Section 3.6, it was shown that the formation of 
glycofluorophores on delipidated HSA was enhanced by products of glucose oxidation 
reactions. Unfortunately it is not possible to determine the contribution of this reaction 
beyond two days as the rates of fluorophore production are identical in all samples after this 
time. It is unlikely that glucose autoxidation is the mdn route by which glycofluorophores 
are formed, as fluorophore production can occur in HEPES buffer. Further evidence that 
fluorophore formation may not occur via the glucose autoxidation pathway is that the 
Amadori product is formed through a non-metal catalysed reaction pathway [Fu et al,
1992], that Amadori products autoxidise preferentially to glucose [Gilleiy et al, 1988; 
Azevedo et al, 1988], and that fluorophores form via a radical mediated reaction from 
glycated proteins in the absence of glucose [Le Guen et al, 1992].
iii) Role of dicarbonyl intermediates
The experiments carried out in Sections 3.8 and 3.7 provide indirect evidence for a 
dicarbonyl intermediate in the formation of glycofluorophores. Aminoguanidine is not a 
free radical scavenger, but is postulated to scavenge dicarbonyl compounds such as 3- 
deoxyglucosone [Requena et al, 1993; Edelstein and Brownlee, 1992; Oimomi and Igaki, 
1989]. Furthermore, in Section 3,7 it was shown that fhictose is a very potent producer of 
glycofluorophores (when compared to glucose). This can be explained by the ability of 
fhictose to forin 3-deoxyglucosone directly, without going through the Heynes product 
[Shin et al, 1988].
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There is now increasing evidence that 3-deoxyglucosone may play a role in the crosslinking 
of proteins in vivo. Until recently, the crosslinking properties of 3-deoxyglucosone had 
only been shown to exist in vitro [Kato et al, 1987], but a recent publication shows that it 
can be detected in the serum and levels of it are elevated in diabetics and especially so in 
those with nephropathy [Niwa et al, 1993].
4.10.2 Mechanisms of sugar-induced protein fragmentation
Protein fragmentation has been shown here to be metal catalysed (Section 4.3) because 
addition of the transition metal chelator DTP A completely inhibited the glucose induced 
fragmentation. Similarly, the fragmentation of apoprotein B when LDL was incubated 
under oxidative conditions was inhibited by the metal chelator EDTA [Fong et al, 1987], 
and both EDTA and DTP A were found to inhibit the fragmentation of proteins incubated 
with model Amadori compounds [Kawakishi et al^  1990], or with hydrogen peroxide [W olff 
and Dean, 1986].
Previous work has shown fragmentation of HSA in a glycation medium which included Cu? 
[Hunt et al, 1988a]. Hunt also claimed to have observed sugar-induced fragmentation by 
Fe"^ , although the results were not actually shown. My own experiments carried out under 
identical conditions, using Fe^ " as the catalytic transition metal, showed no fragmentation of 
HSA. The iron binding protein transferrin was investigated to see whether fragmentation is 
caused by the high-affinity binding of transition metals to specific sites, since HSA (a copper 
binding protein) fragmented in the presence of Cu", but not Fe"^ . However, transferrin did 
not fragment in the presence o f iron either, showing that tight binding of transition metal to 
protein is not necessary for protein fragmentation. O f the two transition metals 
investigated, only Cu^ * appears to catalyse protein fragmentation. '
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Work done using HEPES buffer (Section 4.5) shows that glucose-induced fragmentation is 
a radical mediated reaction. Similarly, the oxidative fragmentation of LDL was inhibited by 
the radical scavenger vitamin E [Fong et al, 1987] and the glucose induced fragmentation of 
BSA was inhibited by the hydroxyl radical scavengers benzoic acid, deoxyribose and 
sorbitol [Hunt et al, 1988a]. Furthermore, Davies and Deloignore (1987) found that 
hydroxyl radicals on their own were insufficient to fragment BSA, and that fragmentation 
only occurred when both superoxide and molecular oxygen were present in addition to the 
hydroxyl radicals.
There are two possible sources of free radicals in the glucose-induced protein 
fragmentation, the autoxidation of either glucose or the Amadori product. The idea that the 
radicals originate from the autoxidation of glucose is suggested by Hunt et al (1988a). He 
observes a small number of specific fragments and it is therefore likely that some further 
factor is controlling the specificity of this reaction. It is unlikely that this specificity is due 
to the production of radicals at copper binding sites because work done by Marx and 
Chevion (1985) using an ascorbate/copper system, where the specificity of the reaction was r 
due to the copper binding at sites on BSA, produced fragments with different masses from 
those obtained by Hunt. The second possible source of free radicals in the glucose- 
mediated fragmentation is from the autoxidation of Amadori product. Fragmentation of 
BSA incubated with mixtures of copper and model Amadori products was observed by 
Kawakishi et al (1990). I f  autoxidation of Amadori product is the source of free radicals, 
then a certain amount of site specific cleavage might be expected. Therefore this 
mechanism may go some way to explaining why I  obtained bands on fragmentation of HSA, 
even though they were broad and diffuse.
The glucose induced fragmentation of HSA is not affected by bound lipid. The 
fragmentation observed in both forms of DSA (where the delipidated form is more heavily 
fragmented) points to the bound lipid playing no role other than holding the DSA in a more 
compact conformation in which it may be protected. This is slightly surprising as lipid 
bound to HSA reacts through a free radical mediated pathway to form fluorophores. Hunt
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and Dean (1989) found that BSA fragmented in the presence of peroxidising lipids (in the 
form of vesicles). He also showed that fragmentation preceded aggregation induced by 
reactions of protein with the aldehydes that are secondary products o f lipid peroxidation. In 
Figure 3.4.12, no fragmentation of native HSA in the presence of high concentrations of 
iron is seen, but the formation of a small amount of high molecular mass substances is seen. 
It is possible that the lipids bound to HSA are already partially peroxidised [Fletcher and 
Tappel, 1971], so at high concentrations of iron they react Anther to produce aldehyde 
compounds such as MDA which are capable of inducing fluorescence and cross-linking, but 
not fragmentation [Hunt and Dean, 1989].
Preparations of HSA may include traces of proteolytic enzymes [Peters, 1985], but as 
preparations of HSA are heat-treated these enzymes could be denatured. I f  the enzymes are 
at all active in these incubations, then the cleavage of protein by traces of these enzymes 
does only occur when both copper and glucose are present. It was observed by W olff and 
Dean (1986) that radical damage to proteins results in increased susceptibility o f BSA to 
enzymic hydrolysis by both pepsin and trypsin. It has also been shown by Davies et al 
(1987b), that there is a direct relationship between oxidative dénaturation of proteins and 
their increased susceptibility to proteolysis. However, Fong et al (1987), working with 
apoprotein B, found no inhibition of protein fragmentation when proteolytic inhibitors were 
included in the incubation, or when the reactants were heat-treated prior to incubation, 
suggesting that the mechanism of protein fragmentation did not involve proteases.
Further evidence that the cleavage of the protein backbone need not be mediated by 
proteases is the observation that the amount of carbonyl groups increase and yet there is no 
corresponding increase in amino groups when proteins are fragmented under oxidative 
conditions [Davies and Deloignore, 1987]. I f  cleavage of the peptide bond was occurring, 
then equal amounts of these groups would be expected. He suggests a mechanism for 
fragmentation where a proton is abstracted from the a-carbon to form an a-carbon radical, 
which in turn reacts with 0% to produce a peroxyl species. The decomposition o f this
carbon peroxide leads to fragmentation between the a-carbon and the carbonyl carbon so
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that the peptide bond remains intact. A modification of this reaction which explains the 
specificity of radical mediated cleavage of BSA, is that the protein is cleaved at proline 
residues which are attacked by hydroxyl and superoxide radicals [Schuessler and Schilling, 
1984; W olff and Dean, 1986]. The masses of the fi-agments obtained by Schuessler and 
Schilling agreed well with the expected masses of fi-agments derived fi-om cleavage at 
proline residues. Following in vitro glycation, both site-specific (occurring at a proline 
residue) and random fragmentation of the enzyme Cu,Zn-superoxide dismutase were 
observed by Ookawara et al (1992). Using ESR spectroscopy, they were able to show that 
reactive oxygen species, formed by the Maillard reaction, were involved in both 
fi-agmentations. Furthermore, they showed that the random fi*agmentation proceeds via a 
Fenton type reaction.
4.10.3 Conclusions
Both fluorophore formation and protein fragmentation are dependent on glucose and 
transition metal catalysts, showing that they are both glycoxidative reactions. Theoretically 
all reactions between organic compounds and molecular oxygen are not only metal 
catalysed, but are also free radical mediated processes. From this thesis, it is clear that 
protein fragmentation and the lipid component of fluorophore formation are indeed free 
radical mediated reactions. However, the role of free radicals in the lipid-independent 
component o f glycofluorophore formation is less clear. The absence of any inhibitory effect 
by HEPES could be because free radicals produced at metal binding sites act at the site of 
their production, and are therefore not scavenged by HEPES.
As both fragmentation and the lipid-component of fluorophore formation are inhibited by 
the use of HEPES buffer, it is likely that these radical reactions occur at the surface of the 
protein where the radical produced can easily be scavenged. In fi-agmentation, more than 
one radical species may be involved, and bound lipids are on the surface of the protein 
making the radicals of both these reactions vulnerable to scavenging.
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The probable role of 3-deoxyglucosone as an early intermediate in fluorophore formation 
does not exclude the possibility that a later reaction in the sequence involves free radicals. 
Indeed, as no fluorescence is seen without metal-catalysed oxidation, it is very likely that 
fi*ee radicals are involved in one of the steps of this reaction sequence.
Preincubation studies showed that glucose autoxidation products can mediate the formation 
of fluorophores, however, I  was unable to determine whether or not this was a major 
pathway. ^
4.10.4 Future work
Future work on this project could include the direct incubation of proteins with 3- 
deoxyglucosone with different inhibitors, in order to determine if  much of what has been 
observed is due to an intermediate such as 3-deoxyglucosone. This may also help to 
determine how dependent the reactions here are on glucose autoxidation.
Examination of cross-linking of HSA induced by glucose, 3-deoxyglucosone, MDA or lipid/ 
would be a natural extension from the observation of oligomers of native HSA when 
incubated with high concentrations of iron. Further work along this line could include 
incubating HSA with collagen (or other structural proteins) in the presence of glucose, 3- 
deoxyglucosone, MDA or lipid and seeing if  adducts were formed between the two types of 
protein. This could contribute toward a model for the formation of diabetic complications 
such as the alteration in the filtration properties o f the glomerular basement membrane.
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